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" ... sport is the play of the spirit, the challenge of the mind, 
and the perfection of the body - not a contest of pharmacology.fl 
(Wadler & Hainline, 1989) 
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ABSTRACT 
During the 1988 Olympic Games, an Australian pentathlete was 
ousted when a random urine test proved positive to a prohibited amount of 
caffeine after competing in 12 hours of fencing. This thesis begins with a 
literature review about caffeine in general, and about its use in sport. 
The present research was carried out to investigate the incidence of 
caffeine abuse among New Zealand athletes, and their use of caffeine as a 
performance enhancing drug. A positive association amongst expectancies, 
caffeine consumption and caffeinism signs was predicted. It was also 
hypothesised that athletes who use caffeine as a performance enhancing 
drug would identity more strongly with the athlete role. 
A survey questionnaire was designed to collect self report data on: 
daily caffeine consumption, DSMIII-R caffeinism symptoms experienced 
after consuming caffeine, expectations of caffeine-enhanced performance, 
and the extent to which subjects identify with the athlete role. 
Respondents were 185 athletes across twelve sporting codes. The data 
were analysed using multiple regression, chi-square analyses and analyses of 
variance. 24.3% of the athletes reported using caffeine as a performance 
enhancing drug. 24.9% endorsed more than 5 symptoms of caffeinism. 
26.5% of the sample believed caffeine can enhance sports performance and 
51.4% of the sample identified strongly with the athlete role. 
This study found a significant relationship between expectancy scores 
and caffeinism symptoms at the .01 significance level, but no relationship 
was found between expectancy scores and caffeine consumption. A 
statistically significant relationship was found for athletic identity and use of 
caffeine as a performance enhancing drug (p<.001). 
The results of this study support the suggestion that caffeine be included in 
drug education programmes despite its ubiquity and legality. Suggestions 
for future research are made and implications for athletes are discussed. 
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During the 1988 Games in Seoul, a pentathlete became the first 
Australian to be expelled from the Olympics over drugs. His urine test 
showed an abnormally high level of caffeine following twelve gruelling 
hours of fencing competition (Christchurch Press, 1988a&b). This 
disqualification implied that the caffeine augmented his performance. 
Athletes select caffeine-containing beverages for many reasons, probably in 
part for their physiological and psychological effects. The belief among 
athletes that caffeine is an ergogenic aid is common, and several governing 
bodies of sport have barred use of the drug during competition. 
Chapter one of this paper provides a summary of caffeine research. The 
focus is first on the historical aspects of caffeine, its sources and properties. 
Then, literature discussing the pharmacological effects of caffeine on the 
various body systems is presented. Chapter two discusses doping controls 
and some of the methodological issues relating to the ergogenicity of 
caffeine in sport. Finally, some of the conflicting evidence as to caffeine's 
use during different types of exercise is presented. 
Care has been taken to present the research in a scientific and unbiased 
manner. However, philosophical and psychological implications are 
necessary when discussing the emotionally packed issues involved in the 
use of performance enhancing drugs. Every study has limitations. No study 
can be completely controlled, contain no false assumptions, or cover every 
eventuality. However, coaches and athletes are seeking factual and scientific 
evidence concerning the use of drugs, and the following review will give 
that evidence for caffeine. 
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CHAPTER ONE: CAFFEINE 
Historical Aspects 
It is thought that Palaeolithic man first discovered caffeine in plants and 
used it in drinks (McNaughton & Minikin, 1990). Certainly its consumption 
goes back as early as the origins of tea in China around 4700 BC. The appeal 
of caffeine lies primarily in its central nervous system (CNS) stimulating 
effect eulogised in the literature. According to legend, an Arabian goat 
herder in Yemen (c.850ADt noted his goats frisking around after chewing 
the berries of coffee beans (Murray, 1988). At the Ancient Olympic Games 
and in Ancient Egypt athletes ingested various substances believed to 
improve their physical capabilities. Similarly, Roman gladiators and 
knights in medieval jousts used stimulants (perhaps caffeine) after 
sustaining injury to enable them to continue in combat (Waddington & 
Murphy, 1993). During the 19th century, athletes also reportedly 
experimented with caffeine (Wadler & Hainline, 1989). 
The recent explosion of recreational drug abuse in the Western World 
(Lucking, 1985) has added a new dimension to the problem of drug abuse in 
sport. Where caffeine used to be taken predominantly as a 'recreational' 
drug, athletes now often rely on its pharmacological properties for 
performance enhancement. Its basic action is to increase alertness and offset 
fatigue by affecting the CNS. 
Although the media coverage of caffeine has not been as extensive as 
drugs such as anabolic steroids, it has been acknowledged. At the Seoul 
Olympics, Steve Hegg, a United States' cyclist and Alexander Watson, an 
Australian pentathlete, were both disqualified after failing drug tests for 
caffeine. Dyment (1987) even suggests caffeine is replacing amphetamine as 
the psychomotor stimulant of choice for many athletes. Indeed, a 
combination of caffeine and ephedrine (more readily available than 
amphetamine) may mimic the actions of amphetamine, producing the 
same type of central stimulation and reduction of fatigue in athletes 
(Lombardo, 1986). 
The use of caffeine as an ergogenic agent cannot be denied. However, 
because of its ubiquitous nature, many people use this substance without 
acknowledging it as a drug. The effect of caffeine is generally expressed in 
the following way: "a mild stimulant, helpful in temporarily relieving 
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minor fatigue and boredom with little risk of any harmful effects" (Graham, 
1978). It is a substance consumed by people in almost all age groups. Many 
soft drinks contain caffeine so people start consuming it at an early age. The 
sports world is often said to be a microcosm of society (Taylor, 1990; Hemery, 
1986) so it is not surprising that athletes are consuming caffeine. 
To date, only limited New Zealand data on caffeine consumption are 
available (Russel & Wilson, 1991). However, an Australian study (Leonard 
et al., 1987) determined the average caffeine consumption for adults as 
240mg per day. The New Zealand average may resemble this due to 
similarities in eating patterns. The New Zealand population derives 70-80% 
of its caffeine from tea (Phelps & Phelps, 1988). The LINZ survey (Appendix 
1 & 2) reports that the beverages most frequently consumed by New 
Zealanders are, in order: tea (23 cups per week); coffee (19 cups per week); 
and water (15 glasses per week; Russel & Wilson, 1991). 
Sources of Caffeine 
The compounds responsible for the stimulating action of coffee, tea1 and 
cocoa are methyl derivatives of xanthine (2,6-dihydroxypurine). They are 
purine-based compounds containing two condensed heterocyclic rings1 and 
are naturally occurring chemicals found in the leaves1 seeds, and fruit of 
more than 60 species of plants. Caffeine is found in tea (Thea sinensis), 
coffee (Coffea arabica), cola nuts (Cola acuminata and Cola nitida), and 
many other plants (Graham, 1978). Caffeine is readily extracted from its 
plant sources and is very soluble in boiling water. Although the caffeine of 
tea leaves exceeds that of coffee beans, much more dilution is usually noted 
in a cup of tea (Falls1 1968). Plant variety1 geographic location1 climate and 
cultural practices including fermentation, influence the content of caffeine 
in natural products (Graham, 1978). 
If not in what people drink1 caffeine is eaten in foods - baked goods, 
chocolate, lollies and many processed foods as a flavouring agent (Watson, 
1988). It is also consumed in common medications1 both prescription and 
nonprescription. According to the Food and Drug Administration's 
National Centre of Drugs and Biologics1 more than 1000 over-the-counter 
drugs show caffeine as a listed ingredient (Lecos, 1984). Standard average 
caffeine contents for various items, are shown in Table 1. 
5 
Tablel 
Caffeine Content of Some Common Items 
Beverage Volume Caffeine Content Range Equiv. in urine 
(mg) Average (mg) within 2-3 Hrs 
Coffee• 150ml 
Brewed, drip method 115 60-180 1.5µg/ml 
Brewed, percolator 80 40-170 
Instant 65 30-120 
Decaffeinated, brewed 3 2- 5 .03-.04µg/ml 
Decaffeinated, instant 2 1- 5 
Tea a 150ml 
Brewed 50 20-110 
Instant 30 25- 50 
Cocoa beverage 150ml 4 2- 20 
Chocolate milk beverage 250ml 5 2- 7 
Milk chocolate 30g 6 1- 15 
Dark chocolate 30g 20 5- 35 
Soft Drinksb 375ml 
Mountain Dew 54 
Coca-Cola 45.6 .68µg/ml 
Diet Coke 45.6 .68µg/ml 
Pepsi-Cola 38.4 
Diet Pepsi 36.0 .54µg/ml 
Prescription Drugs 
Cafergot (antimigraine) lO0mg/ tablet 
Migril (antimigraine/ anti-emetic) lO0mg/ tablet 
Ergodryl (antimigraine) lO0mg/tablet 
Nonprescription Drugs (Pharmacy Only Medicines and Over the Counter Drugs) 
Weight-Control Aids 
Medislim Weight Control Tablets 
Trim Tabs 





Anacin, Maximum Strength Anacin 
Diuretics 
Cold/ Allergy Remedies 
Codral Cold & Flu 
Endacol-C 
Drixine Cough Suppressant 
Medi-Tab Hay Fever Tablets 












Note: Taken from Heel, 1989; Lecos, 1984; Slavin & Joensen, 1985; Wadler & Hainline, 1989 
(Similar items are given different values for caffeine content by various authors.) 
a With coffee and tea, caffeine content also depends on brewing time. 
b About half the caffeine comes from kola beans and half is added (Graham, 1978). 
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Chemistry of Caffeine 
Caffeine is a methylated xanthine (Figure 1). Xanthine per se is a 
dioxypurine, and it is structurally related to uric acid. Caffeine is 1,3,7-
trimethylxanthine. The methylation of position 1 accounts for the CNS 
stimulation, the methylation of position 3 is predominantly responsible for 
the diuretic effect, and the methylation of the 7 position correlates with 
cardiac stimulation (Wadler and Hainline, 1989). 
Figure 1- The structural formula of caffeine, an alkaloid consisting two heterocyclic rings 
with three methyl groups attached. 
Absorption, Distribution, and Metabolism 
Caffeine empties rapidly from the stomach after oral, rectal or parenteral 
administration and is absorbed from the gastrointestinal tract (McNaughton 
& Minikin, 1990). With ingestion of 250mg, significant amounts appear in 
the plasma within 15 minutes (Powers & Dodd, 1985), and peak 
concentrations are reached at approximately 60 minutes regardless of dose 
(Bellet et al., 1968). However, there are subject differences in the 
distribution, metabolism and excretion of the drug (Sawyer et al., 1983). 
Once absorbed, caffeine is distributed in approximate proportion to 
tissue water content. Thus dosage, body composition (Schreiber et al., 
1988b), and hydration state influence a subject's physiological response(s). 
There is no uniformity in the literature conc~rning the plasma half-life 
of caffeine (Curatolo & Robertson, 1983; Stavric, 1988) but the range appears 
to be between 3.0 and 7.5 hours. Factors influencing the rate of elimination 
of caffeine from the body include genetic factors, diet, urinary volume and 
pH, disease states, endocrine status, smoking, concurrent drug use such as 
oral contraceptives, pregnancy, and even ethnic origin (Davis, 1990; Delbeke 
& Debackere, 1984; Kuznicki & Turner, 1985; Sawyer et al., 1982). 
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Caffeine is primarily degraded via hepatic metabolism and its excretion 
as single methyl-group xanthines and methyl-uric acids is primarily renal, 
with little appearing in the faeces (Delbeke & Debackere, 1984). 
Approximately 3% of caffeine is excreted unchanged (Graham, 1978). The 
hepatic clearance of caffeine depends on hepatic blood flow. Caffeine's 
catabolism and elimination from the body during sports are decreased, 
relative to intensity of effort, due to sympathetic activity and the resultant 
decrease of blood flow to the liver (Duthel et al. 1991). Interestingly, van der 
Merwe et al. (1991) found that excessive sweating during endurance exercise 
does not enhance urinary caffeine concentration. 
Mechanism of Xanthine Action 
Xanthines share several common pharmacological actions, caffeine 
being the most active on the CNS. General actions include stimulation of: 
the CNS; the heart and skeletal muscles; the kidneys, inducing diuresis; 
respiratory rate and depth; and possibly the adrenal glands (Table 2). 
Xanthines may also induce relaxation of smooth muscle, stimulate gastric 
secretion, and elevate plasma-free fatty acid and glucose concentration. 
There is also the possibility that the drug may alter the release, binding, or 
activity of neurotransmitters in the brain, thus affecting 'perception' of work 
intensity. To provide the background information needed to appreciate 
caffeine's potential ergogenic effects, a discussion of caffeine's effects on the 
above tissues and processes will follow. Each disclosure will provide basic 
information concerning the qualitative pharmacological effects of caffeine. 
Cellular Basis for Caffeine Action It appears that caffeine acts as a 
neurotransmitter. A number of cellular mechanisms have been proposed 
to explain the CNS stimulant effects of caffeine. Of particular importance 
are those actions of caffeine that might affect work performance by direct or 
indirect effects on the cardio-respiratory system, the nervous system, skeletal 
muscle and/ or shifts in substrate metabolism. In order of caffeine 
sensitivity, these mechanisms are: translocation of intracellular calcium; 
actions mediated by the accumulation of cyclic-adenosine monophosphate 
(c-AMP); and actions caused by the blockade of adenosine receptors. 
Table2 
The effects of caffeine on human physiologya 









Force of contractions 
Compensatory vagal activity 
Circulation 
Coronary & Pulmonary 
Skeletal muscle 







































a Adapted from Sawyer et al. (1982) and Passmore et al. (1987). 
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b Effects reported as increasing or decreasing are those where compensatory vagal activity 
plays a role in determining the final outcome. · 
Firstly, in vitro studies of the effects of caffeine on translocation of 
intracellular calcium (Ca2+) suggest that an alteration of Ca2+ permeability 
occurs in the sarcoplasmic reticulum of muscle. This results in an increase 
of Ca2+ release. This may augment the force of skeletal muscle contraction 
(Van Handet 1983). 
The second cellular mechanism of caffeine action is related to the 
inhibition of the enzyme phosphodiesterase (PDE; Waldeck1 1973). PDE 
catalyses the degradation of c-AMP to 5'AMP. Of interest in exercise is the 
role that c-AMP plays in regulating hormone-induced glycogenolysis and 
lipolysis (Wadler & Hainline, 1989). 
9 
Thirdly,, through competitive antagonism, caffeine blocks adenosine 
receptors. The resulting blockade of the sedative effects of adenosine 
(Weinhold, 1991) leads to CNS stimulation (Powers & Dodd, 1985; Table 3). 
Table 3. 
The contrasting effects of adenosine and caffeine * 







release of catecholamines 















These effects are reversed in CA withdrawal and after the development of CA tolerance. 
Effects on the Central Nervous System 
Caffeine passes the blood brain barrier and is characterised as a powerful 
CNS stimulant affecting the medulla, all portions of the cortex and the 
spinal cord (Murray, 1988). It has many effects on the CNS and may 
influence psychomotor coordination, electroencephalographic (EEG) spectra,, 
sleep, mood, behaviour and cognition (Curatolo & Robertson, 1983; Sawyer 
et al., 1981). 
The molecular basis for caffeine's effects on the CNS is unclear. The 
behavioural effects could result from blockade of adenosine receptors, rather 
than from inhibition of PDE and the resultant accumulation of c-AMP 
(Jacobson & Edwards, 1990; Powers & Dodd, 1985; SICW, 1980). This is 
because the adenosine antagonist action occurs at much lower 
concentrations than are needed for inhibition of PDE (SICW, 1980). 
Caffeine increases the catecholamine neurotransmitters, especially 
epinephrine (EPI; Graham & Spriet, 1991) and norepinephrine (NE; Bellet et 
al., 1968, 1969; Innes and Neckerson,, 1975; Van Handel et al., 1979; Waldeck, 
1973). This is consistent with a generalised stimulation of the sympathetic 
nervous system (Bellet et al., 1969) due to the direct effect of caffeine on the 
adrenal medulla. These observations suggest a possible conflict between the 
direct effects of caffeine on adenosine receptors and the indirect effects of 
caffeine-induced catecholamine release. 
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The arousing effects of stress1 exercise and caffeine are similar (Lane & 
Williams, 1985; Raitliff-Crain et al., 1989). Caffeine stimulates the adrenal 
medulla to secrete hormones that affect the autonomic nervous system 
(cardiovascular and metabolic variables), and which are closely associated 
with emotion, stress and arousal (DeMeersman et al., 1986; Sawyer et al., 









Figure 2 - Exercise-induced discharge of the corticotropin-releasing factor (CRF) with: (1) 
stimulation of ACTH and ~-endorphin release from the anterior pituitary, followed by 
secretion of corticosteroids, and (2) activation of the sympathetic nervous system within the 
brain, followed by adreno-medullary secretion of EPI and NE. Caffeine potentiates this 
response. Adapted from Harber & Sutton (1984) and Sutton (1985). 
Besides NE and EPI, caffeine elevates brain levels of serotonin (5-HT), 
and causes an increase, followed by a rapid decrease, in dopamine formation 
(Waldeck, 1973). Dopamine serves as a precursor for EPI and NE, and has its 
own receptors and functions: increasing heart rate, cardiac output, and blood 
pressure, as well as inhibiting insulin. Caffeine also affects gamma-
aminobutyric acid (GABA) which contributes to the control of spinal 
reflexes, and acetylcholine release. 
Evidence suggests that many of the cardiovascular, analgesic, and 
behavioural effects of exercise are mediated by endorphins, the brain's 
opioid (Farrel et al., 1982; Harber & Sutton, 1984; Sforza, 1988; Sutton, 1985; 
Thoren et al., 1990). These effects could increase an athlete's ability to 
sustain physical effort (Shyu et al., 1982). Caffeine's effects on beta-
endorphin secretion are not completely understood but it probably indirectly 
causes hypothalamic stimulation of pituitary ~-endorphin secretion 
(Rodrigues et al., 1990). Caffeine also acts on hypothalamic releasing factors, 
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hindering the secretion of growth hormone and thyrotropic releasing factor. 
However, it seems unlikely that the doses of caffeine usually consumed 
would produce significant endocrine effects (Rodrigues et al., 1990). 
Mood, Vigilance and Anxiety Caffeine is thought to have stimulant-
like behavioural effects on mood (Kuznicki and Turner, 1986). The general 
belief is that caffeine allays drowsiness and fatigue, enhances perception of 
sensory stimuli, and reduces reaction time. However, conflicting data exist 
regarding caffeine1 s effects on concentration, drowsiness, fatigue and 
vigilance (Wadler & Hainline, 1989). Lieberman et al. (1987) and Kerr et al. 
(1991) observed significant effects of caffeine on vigilance but not mood 
state. Zwyghuizen-Doorenbos et al. (1990) found that caffeine (250mg) 
improved alertness and Goldstein et al. (1965) found increased alertness 
after 100-300mg caffeine. This facilitatory effect of caffeine on vigilance may 
be due to the drug combating fatigue-related decrements seen during control 
conditions (Goldstein et al., 1965). Caffeine's inhibition of PDE could 
account for this finding (Murray1 1988). Others (Lieberman et al., 1987) 
suggest that caffeine's positive effects are not limited to situations where 
fatigue is present, but may be more general. 
Kuznicki and Turner (1986) suggest that an optimum caffeine dose 
might exist for peak alertness to tension ratios. Evidence indicates that high 
levels of caffeine consumption relate directly to high anxiety levels (Sawyer 
et al., 1982). Caffeine's influence on anxiety may interact with situational 
variables, such as the competitive sports arena, causing subclinical anxiety 
levels rise to rise to clinical levels (Davidson & Smith, 1991). 
Caffeine-induced changes in anxiety, reaction time, vigilance, and motor 
skills may affect the efficiency, accuracy and stress levels of athletes. It is 
important to note that caffeine reacts with other drugs such as 
pseudoephedrine and phenylephrine. Also, caffeine reduces the 
performance impairments of the benzodiazepines (Johnson et al., 1990) but 
not alcohol (Smith et al., 1991). Regardless of the mechanism (direct or 
indirect), caffeine is able to act upon the CNS. It has marked effects on 
perception, alertness and wakefulness (Goldstein et al., 1965), and on fatigue 
during muscular work (Costill et al., 1978; Ivy et al., 1979). 
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Effects on the Heart and Vasculature 
The cardiovascular effects of caffeine are mediated through the 
stimulation of the medullary respiratory centre of the CNS and/ or direct 
action on the heart and vessels. All parts of the circulatory system are 
directly affected by caffeine and these actions may be antagonised by 
caffeine's stimulation of compensatory vagal centres in the medulla. For 
example, the cardiac muscle is strongly and directly stimulated by caffeine, 
increasing the heart rate and the force of its contractions. At the same time, 
caffeine stimulates the medullary vagal nuclei, which decreases the heart 
rate. This antagonistic action may result in bradycardia, tachycardia, or no 
change in heart rate (Murray, 1988). This might explain the various findings 
regarding caffeine's effects on heart rate. Some studies have reported an 
elevated exercise heart rate (McNaughton, 1986), others a slowing of heart 
rate (Horst et al., 1936) and others, no change in heart rate (Fisher et al., 
1986). 
Caffeine also has an antagonistic action on the blood circulation. It 
causes the smooth muscles of coronary, pulmonary, and general systemic 
blood vessel walls to dilate. It simultaneously stimulates the medullary 
vasomotor centre, which causes constriction of these vessels, decreasing 
cerebral blood flow. No compensatory activity by the medulla occurs there. 
Smith et al. (1991) reported no effect of caffeine on pulse rate but a 
significant increase in blood pressure. Passmore et al. (1987) also reported 
increased diastolic and systolic pressures. The blood pressure response to 
caffeine depends on the balance between central vasomotor and myocardial 
stimulation, which tend to increase it (Van Handel et al., 1979) and vagal 
stimulation and peripheral blood vessel dilation, which tend to decrease it 
(Smith et al., 1991). This homeostatic mechanism results in few life-
threatening side-effects from caffeine use. However, caffeine does alter the 
volume and distribution of blood, thus affecting substrate and waste product 
distribution during exercise. 
The cardiac index increases following caffeine are probably due to 
enhanced contractility (Ivy et al., 1979). At an electrophysiological level, 
caffeine may affect the rate of calcium exchange, which is responsible for the 
heart's contractility. The increased release of calcium from the sarcoplasmic 
reticulum can result in an oscillatory potential at the beginning of diastoles, 
which could contribute to the onset of arrythmias. 
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The cardiovascular effects of caffeine differ between caffeine-tolerant and 
caffeine-naive individuals (Curatolo & Robertson, 1983). Whereas the latter 
may experience altered haemodynamics (pressor response and increase in 
heart ratet chronic caffeine ingestion has little effect on blood pressure, 
heart rate or plasma catecholamines (Myers, 1988). 
Respiratory Effects 
Caffeine appears to have a respiogenic effect, increasing respiration rate 
and oxygen consumption (Berry et al., 1991; Murray, 1988; Powers, 1983). 
The mechanism for these changes is unknown although as a respiratory 
centre stimulant, caffeine may: increase central chemosensitivity to carbon 
dioxide (CO2) such that its elimination is increased (Powers et al., 1985); act 
directly to stimulate the respiratory medullary complex; affect the inputs 
from the respiratory chemoreceptors; and act directly on neuromuscular 
transmission of the respiratory muscles (Murray, 1988). 
One of the pharmacological effects of caffeine is relaxation of the smooth 
muscles of the bronchi (Curatolo & Robertson, 1983). In 1990, Kivity et al. 
showed that as well as a general bronchodilating effect, caffeine also has a 
protective value on exercise-induced bronchoconstriction (EIB) in 
asthmatics. This effect is only seen at large doses (7mg.kt1) which seem 
impractical to ingest before exercise. 
Effects on Skeletal Muscle 
Caffeine distributes in the body water1 and is therefore most 
concentrated in skeletal muscle (Power & Dodd1 1985). Because tissue 
response is proportional to xanthine concentration1 significant effects on 
muscle could be expected and may include enhanced contractile status1 
altered patterns of fibre recruitment and substrate mobilisation, and shifts in 
the rate of substrate use. These actions are mediated by direct actions on 
muscle or indirectly through alterations in hormone status (Figure 3). 
Contractile Status It is well established by in vitro studies that caffeine 
has a direct effect on muscle contraction (Hartree & Hill, 1924; Powers & 
Dodd1 1988; Waldeck, 1973). Evidence suggests that caffeine potentiates the 
contractile capacity of both fatigued and rested muscle stimulated in situ. 
(Bianchi1 1962; Huidobro & Amenabar1 1945) and facilitates neuromuscular 
impulse transmission (Huidobro & Amenabar1 1945; Waldeck, 1973). 
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Finally, Lopes et al. (1983) have demonstrated that caffeine has a positive 
effect on human skeletal muscle properties in vivo both before and after 
muscle fatigue. These phenomena are apparently related to alterations in 
the release, uptake, or storage capacity of the sarcoplasmic reticulum for 
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Figure 3 - Possible role of caffeine in the regulation of muscle actions. These include both 
direct and indirect mechanisms (clockwise from left): alteration of neuron threshold (1), 
stimulation of NT release (2), alteration of sarcolemma threshold (3), alteration of membrane 
activity related to calcium storage (4), inhibition of adenosine binding (5) and PDE activity 
(6), stimulation of catecholamine release (7), that, in tum, increases cAMP activity. The 
latter activates protein kinases that turn on glycogenolysis (10), lipolysis (11), and 
contractility (13). In addition, caffeine may inhibit glycogenolysis (8), increase blood glucose 
levels (9), and induce FFA mobilisation from adipose tissue (12). From Van Handel (1983). 
There are four intracellular mechanisms by which caffeine directly 
exerts its effects on calcium. Caffeine may: rapidly release calcium from the 
sarcoplasmic reticulum; decrease the rate of calcium uptake by the 
sarcoplasmic reticulum; induce a loss of membrane integrity resulting in the 
increased calcium permeability of the sarcolemma; and, increase 
intracellular c-AMP levels by PDE inhibition. The last, in turn, may induce 
protein kinase-catalysed phosphorylation and increase Ca2+ uptake by the 
reticulum calcium pump. Caffeine's effects on skeletal muscle contractility 
may be mediated by all four of the above cited events. Williams (1991) 
reviews these mechanisms excellently. 
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Substrate Mobilisation and Use The second major area of caffeine 
effects on muscle is related to alterations in the lipid and carbohydrate 
storage pools (adipose and liver tissues, respectively) as well as direct actions 
on muscle itself (Spriet et al., 1992). Potentially these actions may provide 
the most dramatic effects on work output under in vivo conditions (Van 
Handel, 1983). The mechanism is dependent upon caffeine altering the 
concentration or activity of c-AMP or of several regulating enzymes. 
Caffeine increases cellular c-AMP by two mechanisms (Figure 4). First, 
by sensitising central catecholamine receptors (Hartman & Becker, 1972), 
circulating catecholamine levels are raised (Bellet et al., 1968; Graham, 1978). 
This increases adenyl cyclase activity with consequently greater production 
of c-AMP. Second, caffeine inhibits PDE (Waldeck, 1973), the enzyme that 
catalyses the conversion of c-AMP to 5'-AMP (Powers & Dodd, 1985). The 
resulting increased c-AMP1 in turn, gives rise to increased glycogenolysis 
(increased blood sugar) in caffeine-naive subjects and to increased lipolysis 
(increased free fatty acids) in all subjects (Curatolo & Robertson, 1983; Powers 
& Dodd, 1985). 
/Caffeine~ 
I circulating catecholamines (NE & EPI) ::\ inhibit PDE 
ij ij 
I adenyl cyclase c-AMP ~ 5' AMP 
ij ij 
I c-AMP production I available c-AMP 
ij ~-------------- ij 
I glycogenolysis ~-------- ·· ··· . . -_~I lipolysis 
ij ij 
I blood sugar I free fatty acids 
Figure 4 - Pathway of caffeine-induced increased glycogenolysis and lipolysis. 
Glucose Homeostasis Caffeine alters glucose homeostasis by increased 
glycogenolysis, having a hyperglycaemic action (Cheraskin et al., 1967; 
Graham1 1978) through activation of phosphorylase in liver tissue. This is 
dependent upon either caffeine-induced increases in blood catecholamine 
levels (Bellet et al.1 1969; Van Handel et al.1 1983), or a direct inhibition of 
phophodiesterase (Waldeck, 1973; Figure 4). The resultant increase in c-
AMP from either mechanism activates a protein kinase that accelerates 
phosphorylase activity, stimulating hepatic glycogenolysis (Bjorntorp1 1993). 
As a result of the stimulation of glycogenolysis, there appears to be a release 
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of glucose into the peripheral system that induces insulin secretion, 
potentially making the glucose available for peripheral uptake and 
metabolism. Whether this sequence of events occurs in vivo is unclear, 
however, since the adipokinetic effects (see below) of caffeine (Bellet et al., 
1968; Weir et al., 1987) are well established and would likely suppress 
peripheral glucose uptake and oxidation. 
Blood Lipids Caffeine stimulates lipolysis (Bellet et al., 1968, 1969; 
Costill et al., 1978; Essig et al., 1980, Ivy et al., 1979, McNaughton, 1986; 
Wilcox, 1982) in adipose tissue which results in increased plasma levels of 
free fatty acids (FFA; Costill et al., 1978; Essig et al., 1980; Powers et al., 1983). 
When ingested prior to exercise, caffeine has been reported to delay the 
onset of exhaustion (Costill et al., 1978: Ivy et al., 1979t due to the 
stimulation of FFA mobilisation (Bellet et al., 1965t leading to a glycogen-
sparing effect (Essig et al., 1980; Spriet et al., 1992). The enhanced lipolysis is 
a result of the activation of lipase. Lipase activity can be enhanced by 
caffeine by the same mechanisms mentioned above (Figure 4). 
First, caffeine causes an increase in blood catecholamine levels leading 
to increased intracellular c-AMP. This activates a protein kinase that 
accelerates the phosphorylation of inactive triglyceride lipase. The activated 
lipase then catalyses the hydrolysis of stored triglycerides into FFA and 
glycerol (Bjorntorp, 1991). The second mechanism by which caffeine may 
stimulate lipolysis is by a direct inhibition of PDE (Bellet et al., 1968; Wilcox, 
1982) which contributes to an increased cellular concentration of c-AMP. 
Both the time course for, and the magnitude of elevation o( increase in 
plasma FFA following caffeine ingestion are important considerations for 
the interpretation of ergogenic effects (Costill et al., 1978; Ivy et al., 1979). 
Whereas plasma caffeine concentrations peak about 1 hour following 
ingestion (regardless of closet plasma FFA concentrations do not peak until 
at least 3 to 4 hours after ingestion depending on dose (Bellet et al., 1968, 
1969; Essig et al., 1980; Ivy et al., 1979; Van Handet 1979; Weir et al., 1987). 
The problem with lipid utilisation during exercise is not the physical 
availability of fat as an energy source, but to bring the lipid to the site of 
oxidation in the muscle and have it used in the oxidative processes to 
furnish energy. If this can occur efficiently, then the limited carbohydrate 
(CHO) stores, which are essential for the needs of the brain, can be spared, 
and exercise prolonged. Training increases the capacity of skeletal muscle to 
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use fat as an energy source. An increase in fat metabolism during 
prolonged exercise has a glycogen sparing effect and as such improves 
endurance capacity. Fat cells increase their sensitivity to hormonal 
stimulation after training (Bjorntorp, 1991) and as a result mobilisation of 
fatty acid more closely matches utilisation. 
Direct Measures of Muscle Lipid and Carbohydrate Use Indirect 
estimates of in vivo carbohydrate and lipid utilisation during exercise have 
implicated caffeine as a modulator of substrate mobilisation, uptake, and 
metabolism. Some information suggests that although caffeine may 
increase use of blood-borne FFA, it also affects muscle triglyceride use (Essig 
et al., 1980; McNaughton, 1986). 
In one study, subjects cycled for 30 minutes at 70% of their maximum 
oxygen consumption (V02max). Caffeine (5 milligrams per kilogram of 
body weight; mg.kg-1) was ingested 1 hour before exercise. Although there 
was an 18% increase in plasma FFA by the start of exercise, glycogen use was 
decreased by 42% and triglyceride was increased by 60% over control 
conditions. Estimates of substrate oxidation. based upon respiratory 
exchange indicated that the subjects used 22% less carbohydrate during the 
30 minutes of exercise following the caffeine ingestion. It was clear that 
caffeine altered use of endogenous muscle triglyceride (Essig et al., 1980). 
These data support the suggestion that the 1sparint of carbohydrate and 
improved endurance performance following caffeine administration are, at 
least in part, due to the altered rates of metabolism of intracellular substrate 
as opposed to increased uptake and oxidation of mobilised FFA. The latter 
may contribute to the modulation of muscle triglyceride pools. 
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CHAPTER TWO: CAFFEINE IN SPORT 
Classification of Caffeine as a Doping Agent 
Regardless of the ability of caffeine to induce a true ergogenic effect 
(Perkins and Williams, 1975), it has long been considered a doping agent 
that could enhance performance (Flinn et al., 1990). This led to its 
prohibition in athletic events. However, it was removed from the 
International Olympic Committee's (IOC) list of banned drugs in 1972. This 
was perhaps because research findings regarding its ergogenic effects were 
equivocal (Smith & Perry, 1992), that it is a constituent of many common 
beverages and, interestingly, that it is a constituent of a major Olympic 
sponsor's product. The IOC and the New Zealand Olympic and 
Commonwealth Games Association have since placed an upper limit on 
caffeine ingestion among athletes (Price & Weit 1990; Wagner, 1990). 
Caffeine is restricted to 12 micrograms per millilitre (µg.mr1) of urine (New 
Zealand Sports Drug Association, 1994). 
This level of caffeine is likely to be attained by injections or 
suppositories. Otherwise, to reach the upper allowable limit, Wagner (1990) 
suggests an athlete would have to ingest 6 cups in one sitting, an impractical 
exercise before competition. However, Birkett et al. (1990) showed that the 
limit of 12µg.mr1 could be exceeded by some individuals with low to 
moderate caffeine intake. Therefore, consideration should be given to 
raising the limit, or alternatively, advising athletes to restrict intake to the 
equivalent of 2 to 3 cups of coffee per day. 
The two most usual grounds for objecting to 'doping' are clearly set out 
in the Rules for Control of Banned Substances of the New Zealand Olympic 
and Commonwealth Games Association (NZOCGA, 1989, p. 17): 
There are some who consider that the use of these performance 
enhancing drugs (PEDs) is a development on par with 
improved dietary methods or improved technology and should 
not be penalised. The majority of sports . administrators and 
athletes, however, appear to hold the view that the use of PEDs 
is a form of cheating ... Some of the PEDs are used by athletes in 
amounts far in excess of those used for therapeutic purposes and 
may be dangerous to both physical and mental health . (Italics 
added). 
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The objection could hardly be stated more clearly. The NZOCGA is opposed 
to the use of drugs, first, because it is not fair play, and secondly, because it 
may be damaging to health. 
The three major categories of drugs used by athletes include: 
performance enhancement (ergogenic) drugs for the purpose of gaining 
athletic advantage; therapeutic drugs for specific medical indications; and 
pleasure drugs to alter mood and perceptions. These categories are not 
necessarily mutually exclusive. For example, a pleasure drug, such as 
caffeine, may both reduce anxiety in habitual caffeine users (therapeutic) and 
enhance performance by delaying muscle fatigue in athletes (ergogenic). 
A number of anomalies have been identified in the IOC list of banned 
drugs (Shapiro, 1991). Firstly, caffeine is a drug that can enhance 
performance, yet it is only banned in high doses. Pseudoephedrine, an 
ingredient of many cold remedies, is a therapeutic rather than an ergogenic 
drug. That is, an athlete may be enabled to compete with a cold by taking the 
drug, however it is banned in any quantity. 
Secondly, like the amphetamines, the ergogenicity of caffeine is a 
function of its dose-response curve (Ellinwood & Nikaido, 1987). In this 
regard, it is interesting that caffeine is the only stimulant treated in a dose-
response manner in drug testing protocols. The imposition of a 
quantitative standard for caffeine as contrasted with an 'all-or-none' 
standard for, say amphetamine, reflects both the ubiquity and legality of 
caffeine in society (Graham & Spriet, 1991). 
Thirdly, Duthel et al. (1991) query the validity of the upper authorised 
official limit for urinary caffeine in doping controls after confirming a 
finding of Delbeke & DeBackere (1984) that exercise decreases caffeine 
elimination. On these grounds they suggest that the nature of the sporting 
event as well as sex, weight, and sampling delay after exercise are all factors 
that argue against the utilisation of a unique standard. 
Fourth, caffeine is the only one of 40 stimulants on the IOC banned 
substances list that athletes have unrestricted access to in New Zealand. The 
other 39 are listed as controlled drugs, prescription medicine, restricted 
medicine, or pharmacy-only-medicine (Hatherton, 1991). Of the other 
banned substances in the various doping classes (for example, Anabolic 
Steroids), all 55 registered medicines are restricted in New Zealand. 
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New Zealand introduced a policy against the use of PEDs in sport in 
1989, and this is implemented by the Sports Drug Agency (NZSDA\ 
established by statute in 1994. All sports reliant upon Hillary Commission 
funding must endorse the policy, and ensure its constitution covers testing 
and disciplinary action. Interestingly, the New Zealand Federation of Body 
Builders does not seek government funding and therefore is not obliged to 
test its athletes. Some consider this a blatant admission of guilt. The Task 
Force Report on the Misuse of Drugs in Sport (Hatherton, 1991) 
recommends that athletes in the other eleven sporting codes addressed in 
this paper be tested in the competition season for stimulants (including 
caffeine; Appendix 4). 
Caffeine and its by-products can be measured in urine by 
spectrophotometric methods so that detection is relatively easy (Delbeke & 
Debackere, 1984). However, the exogenous or excessive administration of 
caffeine for doping purposes is difficult to prove, especially if the athlete is 
simultaneously using diuretics. 
Ergogenicity of Caffeine - Methodological Issues 
Two factors need to be considered when discussing the ergogenic effects 
of caffeine in sport. Firstly, 'ergogenic' must be defined. The dictionary 
defines an ergogenic agent as something that "tends to increase work 
output, especially by eliminating fatigue symptoms". Ergogenic aids usually 
refer to substances not found in normal diets that are taken to improve 
performance. Any drug that pharmacologically aids the muscular, 
circulatory, or respiratory system, is a potential ergogenic aid, and thus a 
potential doping agent. The IOC defines 'doping' as the: 
... use by a competing athlete of any substance foreign to the body 
or of any physiological substance taken in abnormal quantity or 
taken by an abnormal route of entry into the body with the sole 
intention of increasing in an artificial and unfair manner his/her 
performance in competition. (cited in Hatherton, 1991; pl8). 
Secondly, there are methodological considerations that make 
interpretation of the data difficult. Determination of the ergogenicity of 
caffeine in a competitive setting is even more difficult than under in vitro 
or in vivo conditions. That no clear pattern of work enhancement exists is 
likely due to the following complicating factors: 
21 
• There is a dose-response effect (Ellinwood & Nikaido, 1987; Kirsch & 
Weixel, 1988; Waldeck, 1973); 
• There are subject differences in sensitivity (Costill et al., 1987; Essig et al., 
1980; Goldstein et al., 1965, 1969; Graham, 1978; Work, 1991) and tolerance 
to caffeine (Essig et al., 1980); 
• There are differences in response between habitual users and non users 
(Bangsbo et al., 1992; Fisher et al., 1986; Goldstein et al., 1965, 1969; 
Kuznicki & Turner, 1986); 
• There are species differences that make extrapolation of animal data 
tenuous (Second International Caffeine Workshop [SICW], 1980); 
• Studies may have been poorly controlled (Schreiber et al., 1988b); 
• The natural sympathetic response to exercise (Sutton, 1985) may mask 
similar responses caused by caffeine; 
• There may be conflicting responses due to both direct and indirect actions 
(Sawyer et al, 1983); 
• There may have been imprec1s10n in the measurement of coffee and 
caffeine intake (Schreiber et al., 1988a&b); 
• Studies may have employed too few subjects or questionable protocols, 
(Kirsch & Weixel, 1988); 
• Some studies have reported the effects of caffeine in situ in muscle while 
others have reported its effects on the whole body (Bianchi, 1962); 
• There may be differences in the type of task (eg. incremental/ progressive 
load versus constant load/steady state) or the exercise intensity (Casal & 
Leon, 1985); 
• There may be conflicting results due to subjects' fitness levels and diets 
(Murray et al., 1989; Schreiber et al., 1988a&b; Weir et al., 1987); 
• The environmental conditions (Doubt & Hsieh, 1991; Sawyer et al., 1983) 
may not have been taken into account; 
• There may have been differences in the athlete pool (eg. runners versus 
cyclists; Casal & Leon, 1985); 
• Subjects' body composition and muscle mass relative to dose may not 
have been accounted for (Essig et al., 1980); 
• Subject selection (male versus female; trained versus untrained; age) may 
have been poor; 
• The exercise protocols used may have been different (eg. open-ended 
versus close-ended tests; Tarnopolsky et al., 1989); and 
• The personality of subjects and time of day the drug is administered may 
not have been accounted for (Smith et al., 1991). 
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Three examples drawn from the above list of confounding factors 
illustrate how confusing it can be to draw firm conclusions regarding the 
ergogenicity of caffeine from the literature. Firstly, two studies involving 
human subjects (Costill et al., 1978; Ivy et al., 1979) gave male and female 
subjects of different body weights and caffeine intakes, absolute caffeine 
doses that, when expressed in relative terms to body weight, were some 50% 
greater for lighter, as compared to heavier, individuals. Moreover, the 
former study administered 5g of decaffeinated coffee in the control drink. 
Decaffeinated coffee has been reported to contain 1-5mg caffeine per cup 
(Table 1) as well as trigonelline and chlorogenic, tanic, caffeic, quinic, acetic, 
propionic, butyric, and valeric acids; ketones; acetonin; furfural; and other 
acidic carbonyl compounds. The pharmacological significance of these 
substances must be considered when discussing the effects of caffeine 
(Knowles, 1990). 
A second example relates to the training effect. Foltz et al. (1943) 
reported that training overshadows any effect caffeine might exert. 
Moreover, Casal & Leon (1985) have suggested that caffeine has an effect 
only on non-elite athletes who have not had the benefit of increased 
lipolytic enzyme activity and mitochondrial density and size that endurance 
training causes. 
Thirdly1 controversy exists regarding the effects of caffeine because of 
failure in many studies to account for acute, chronic and occasional use, 
previous caffeine intake, length of abstention and other interacting factors. 
To ignore these factors will produce a distorted view of the effects of this 
drug on human sports performance and behaviour. 
Caffeine and Sports Performance 
Caffeine has long been consumed by athletes in the belief it will enhance 
performance (Butts & Crowell, 1985; Delbeke & Debackere, 1984; Grollman, 
1930). However, caffeine may be interpreted to have positive, negative, or 
no effects, depending on the population segment (Kuznicki & Turner, 1985) 
and the type of exercise being investigated (Powers & Dodd, 1985; Slavin & 
Joensen, 1985). In addition, as discussed above, there are several design 
problems that make the literature concerning the ergogenic effects of 
caffeine suspect. Thus, this discussion of the effects of caffeine on sports 
performance, must be viewed with regard to those considerations. 
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Long Term Endurance Performance There is considerable evidence that 
caffeine enhances performance in submaximal long term exercise (Table 4). 
Athletes who ingest caffeine prior to an endurance performance can show 
increased lipolysis1 mobilisation of FFA from adipocytes, and increased 
capacity for endurance exercise (Costill et al.1 1978; Flinn et al., 1990; Ivy et al. 1 
1979; McNaughton, 1986; Spriet et al., 1992). During endurance competition, 
the availability of muscle glycogen is a critical factor. The increased 
availability of fat mediated by caffeine ingestion exerts a glycogen-sparing 
effect by inhibiting enzymes (eg. phosphofructokinase) involved in 
carbohydrate metabolism (McNaughton1 1986; Spriet et al.1 1992). 
Early studies indicated that caffeine increases endurance times in fixed 
pace work bouts and decreases times in fixed-distance races. Ivy et al. (1979) 
found that during 2 hours of isokinetic (fixed pace) cycling, administration 
of 500mg caffeine significantly (7.4%) increased work production by trained 
cyclists compared to placebo. Oxygen consumption showed a parallel 
increase while perception of exertion remained unchanged. Estimates of 
substrate utilisation based upon oxygen consumption (VO2) and respiratory 
exchange (RER) data have suggested that caffeine enhances the use of lipids 
during the last half of an exercise task. In a companion study (Costill et al.1 
1978); competitive cyclists were asked to ride at 80% of their maximal oxygen 
uptake (VO2max) until voluntary exhaustion. Those who received caffeine 
continued for over 90 minutes, as opposed to 75 minutes for the control 
group. 
Essig et al. (1980) reported a 42% reduction in glycogen use with a 
Smg.kg-1 dose of caffeine during 30 minutes of cycling at 69% VO2max. 
Plasma FFA were elevated 323% concomitant with a 40% decrease in muscle 
glycogen utilisation. The mechanism behind the increased rate of work 
production and total work output was suggested to be due to an enhanced 
lipid utilisation. The increased oxygen uptake may have been a result of 
caffeine directly stimulating metabolic rate as well as caffeine's positive 
effect on lipolysis and fat utilisation (Van Handet 1983). 
McNaughton (1986) similarly reported an increase m plasma FFA 
concentrations after ingestion of large doses of caffeine (lSmg.kg-1), 
enhancing aerobic running performance. These changes were associated 
with a 'sparing' of glycogen in red muscle and liver1 and higher blood 
glucose levels following exhaustive exercise. There were no effects in fast-
twitch white muscle, probably due to its low ability for fatty acid oxidation. 
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This glycogen sparing effect and an increased rate of lipolysis both 
contributed to an increased time to exhaustion (McNaughton, 1986). This 
effect is consistent with the fact that studies have not shown caffeine to be 
effective during short-term (less than 10 minutes) high-intensity exercise 
such as sprint running, which does not rely upon fat for fuel. 
Giles & McLaren (1984) also reported significantly higher FFA levels, 
and lower respiratory exchange ratio (RER) and perceived exertion (RPE) 
values with caffeine ingestion (5mg.kt1) before and during a submaximal 
treadmill run. A decreased RER suggests a sparing of carbohydrate, or more 
specifically, increased FFA oxidation and lipid metabolism (Costill et al., 
1978; Giles & MacLaren, 1984). Erickson et al. (1987) similarly found a 30% 
reduction in glycogen use following during 90 minutes of cycling at 65-70% 
V02max with a higher caffeine dose (9mg.kt1). 
Recent studies (Graham & Spriet, 1991; Spriet et al., 1992) have also 
demonstrated ergogenic effects of caffeine in recreational cyclists and highly 
trained distance runners. Spriet et al. (1992) demonstrated that the glycogen-
sparing effect occurs even at a relatively intense power output (80% 
V02max) but that this is confined to the initial 15 minutes of exercise. The 
delayed utilisation of glycogen early in exercise appears to enable athletes to 
cycle longer before glycogen depletion and exhaustion occur. It is now 
generally concluded that caffeine does improve endurance performance, 
possibly through increased mobilisation of FFA, which spares muscle 
glycogen for later use (Erickson et al., 1987). However, this carbohydrate-
sparing effect of caffeine has been reported in cyclists even when their 
serum FFA levels were not greatly elevated by of caffeine (Costill et al., 1978; 
Essig et al., 1980; Ivy et al., 1979). Therefore, the actual mechanism by which 
caffeine improves endurance performance might be more complex, 
involving perception of effort and cellular mechanisms._ 
Concomitant with physiological changes during exercise are 
psychological, or perceptual, changes of exercise intensity. Research suggests 
that people exercising at physiologically equivalent work loads perceive 
their effort at varying intensities (Borg, 1970), causing them to either push 
themselves harder or to decrease their intensity of effort. Perceptual effort 
can be quantitatively rated and compared among individuals during 
exercise by the scale of perceived exertion (RPE; Borg, 1982). 
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Table4 
Summary of previous studies of caffeine and aerobic exercise performance* 
Study Exercise Mode, Caffeine dose, Serum Free Fatty Acid Effect of Caffeine on: Pre-test Nutrition 
Intensity, Duration Time Taken Levels during exercise Exercise Lipid Oxidation on Exercise Patterns 
after Caffeine Ingestion Performance durirg exercise of Subjects 
Belle! et al. (1968) Rest 220mg not studied not studied not studied Rested for 1 day, 
11 h postprandial 
Perkins & Williams Progressive to 4/7/10mg/kg not stated ro effect, ro effect, RER 3-4h postprandial 
(1975) exhaustion 30min pre-exercise RPE uncharged unchanged 
Costill et al.. (1978) Cyclirg, 80% VO 2 max 330mg, 60min .3-.5mmoVI, caffeine +Ve +ve, -veRER Rested for 1 day, 
75-90 min pre-exercise had no effect of FF A 6-12h postprandial 
levels 
Ivy et al. (1979) Cyclirg, 69%VO2max 250mg,60min .3-1.0mmoVI, caffeine +ve +ve, -Ve RER Not stated 
120 min pre-exercise, 250mg had no effect on FFA 
durirg exercise levels 
Essig et al. (1980) Cyclirg, 65-75%VO2 max 5mglkg, 60 min .7-.5mmol/l, caffeine not studied +ve, -ve RER & Normal mixed diet, 
30min pre-exercise elevated pre-exercise & muscle glycogen 1 day rest, 12h 
final FFA levels only utilisation postprandial 
Powers et al. (1983) Cyclirg, progressive 5mgtkg, 60min .3-.2mmol/l, caffeine ro effect ro effect, RER Reduced exercise 
to exhaustion pre-exercise had no effect on FFA uncharged for 24h, 6h 
levels postprandial 
Giles & McLaren Treadmil run, 75% 5mgikg, 60min .8-1.BmmoVI, glucose not studied, +ve,-veRER Not stated 
(1984) VO2max, 120min pre-exercise ingestion decreased -ve RPE 
the effect 
Casal & Leon (1984) Treadmill run, 75% 400mg, 60min .7-.9mmol/l, caffeine not studied, ro effect, RER No 'strenuous' run 
VO2max, 45min pre-exercise increased FFA levels -ve RPE unchanged for 24h, normal diet, 
postprandial 
Butts &Crowell (1985) Cycling, 75% VO2max, 250mg, 60min not studied ro effect, ro effect, RER Limited for 24h, 
to exhaustion pre-exercise RPE unchanged uncharged Sh postprandial 
Gaesser & Rich (1985) Cycling, progressive 5mg/kg, 60min not studied not studied ro effect, RER Not stated, 12 h 
to exhaustion pre-exercise unchanged postprandial 
McNaughton (1986) Tread mil run, 15mgikg, 60min .36-.81mmoVI, caffeine +ve, -veRPE +ve, -veRER Not stated 
progressive to pre-exercise increased FF A levels 
exhaustion 
Weir et al. (1987) Treadmill & road 6.5mgtkg, 3h .4-1.0mmoVI, caffeine ro effect, RER uncharged Rested for 2 days, 
run, 75% VO 2 max, pre-exercise had no effect on FFA RPE i1 CHO loaded high CHO diet, 
120min levels in CHO-loaded Ss unchanged subjects 3h postprandial 
Tarnopolsky et al. Tread mil run, 70% 6mglkg, 60min Caffeine increased oo effect, oo effect, RER Rested for 1 day, 
(1989) VO2 max, 90min pre-exercise FFA levels RPE uochanged 3h postprandial 
unchanged 
Finn et al. (1990) Cycling, progressive 1 0mg/kg, 3-4h .1 to .6 mmoVI, CA +ve, not +ve, -ve RER 12h postprandial 
to exhaustion pre-exercise increased FFA levels studied 
Gastin et al., (1990) Running, progressive 5mgikg, 3.5h not studied oo eifect not studied Limited for 24h, 
to exhaustion pre-exercise -ve RPE 12h postprandial 
Spriet et al. (1992) Cyclirg, 80% VO2max 9mgikg, 60min .24 to .46 mmoVI, CA +ve, not +ve RER Normal training, 
to exhaustion pre-exercise increased FFA levels studied 2-4h postprandial 
Wiles et al. (1992) Treadmill run, 1500m 3mg/kg, 60min not stated +ve, -veRPE +ve, -ve RER 12h postprandial 
!!llh intensiti 
'Adapted and extended from Weir et al. {1987) 
ere-exercise 
The abbreviations used are: FF A= free fatty acid; V 02 max = maximal oxygen consumption; RER = respiratory exchange ratio; RPE = rating of perceived exertion; 
+ve = positive effect; -ve = decreased; Ss = subjects; nonsig = nonsigntticant; h = hours; CA = caffeine 
In the study of Costill et al., 1978, there were no differences in heart rate 
or VO2, but the perceived exertion was lower with caffeine. This suggests 
that under some conditions perceived exertion scales may not serve as an 
accurate index of metabolic stress, and that caffeine may mask fatigue 
symptoms. As with amphetamines, caffeine is generally touted as 
improving alertness, concentration, reaction time and energy levels. People 
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taking the drug often feel stronger and more competitive (Wyndham et al., 
1971). They believe they can perform longer before the onset of fatigue and 
that they can push harder in the face of greater physiological stress. This 
reduced perception of fatigue has potentially dangerous implications. A 
cyclist has already died from heat exhaustion while using amphetamine. 
However, this risk is unlikely to exist from caffeine use. 
Rodrigues et al. (1990) also reported that caffeine (5mg.kt1) significantly 
lowers the subjective perception of effort (RPE) during a cycle ride to 
exhaustion but has no significant effect on endurance time, pulmonary 
ventilation, oxygen consumption1 carbon dioxide extraction or respiratory 
exchange ratio. Powers & Dodd (1985) reported similar findings. 
The findings concerned with the RPE may be attributed to metabolic and 
neuromuscular factors. Thus, the reduction in RPE scores with caffeine use 
could be due to a combination of retardation of muscle glycogen breakdown, 
altered neuronal stimulation enhancing recruitment of muscle fibres 
(Waldeck, 1973t or elevated intramuscular calcium concentration 
enhancing muscle contractility (Williams, 1991). It is probable therefore, 
that enhanced lipid metabolism and neuromuscular function combine to 
depress RPE scores throughout exercise when caffeine is ingested (Giles & 
McLaren, 1984). 
Several groups have found no effect of caffeine on performance 
measured by the respiratory exchange ratio. Perkins & Williams (1975) 
found time to exhaustion on a cycle ergometer and RPE were no different to 
control time and RPE with three dosages of caffeine. This study directly 
contradicts the study of McNaughton (1986) even though the studies were 
quite similar. Gaesser and Rich (1985) found that ingestion of 5mg.kg-1 
caffeine did not delay, and might even accelerate the onset of blood lactate 
accumulation. Others (Ben-Ezra & Vaccaro, 1982; Butts & Crowelt 1985; 
Falk et al., 1989; Gastin et al., 1990; Powers et al., 1983) found no significant 
differences in the time to exhaustion between caffeine trials and control 
trials. It should be noted that these studies used a progressive work task in 
favour of steady state exercise. Graded tasks are largely aerobic but they end 
with a maximal anaerobic effort to exhaustion. 
Casal and Leon, 1985) reported that although plasma FFA were elevated 
significantly before exercise after caffeine ingestion, there was no indirect 
evidence of altered substrate utilisation or carbohydrate-sparing during 
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subsequent running. This showed that the psychological influence of 
consuming coffee, regardless of caffeine content, reduced perceived exertion, 
probably through a placebo effect (Fillmore & Vogel-Sprott, 1992). 
Clearly, it remains to be established why caffeine ingestion has a marked 
and reproducible carbohydrate-sparing effect in cyclists independent of its 
effect on serum FFA levels whereas in runners, the carbohydrate-sparing 
effect of caffeine would appear to be dependent on its effect in elevating 
serum FFA levels (Giles & McLaren, 1984). However, even when caffeine 
ingestion elevates serum FFA levels in runners, this does not guarantee 
that there will also be carbohydrate sparing (Casal & Leon, 1985). 
Reasons for the discrepancies between studies (evident in Table 4) are 
not readily apparent, although differences in type of exercise, the intensity, 
the caffeine dose, and subjects' diets may be responsible for such differences 
(Casal & Leon, 1985; Gaesser & Rich, 1985; Tarnopolsky et al., 1989). 
The interaction of diet with the free fatty acid response to caffeine was 
first noted by Bellet et al. (1968). They showed that by itself, caffeine (250mg) 
caused blood FFA levels to rise to levels of .82 millimol per litre (mmol.r1) 
within 3 hours. However, when glucose was ingested simultaneously with 
caffeine, blood FFA levels were depressed for the first 2 hours after ingestion 
and rose to only .49 mmol.r1 after 3 hours. This finding was confirmed by 
Giles and McLaren (1984) who showed that glucose ingestion significantly 
diminished and delayed the FF A response to caffeine. 
Weir et al. (1987) similarly reported that when athletes ate a high 
carbohydrate (CHO) diet and rested for 3 days ('carbohydrate-loading') before 
exercise, caffeine did not affect serum FFA levels. This raises two practical 
issues. First, it shows that the combination of carbohydrate-loading and a 
high CHO pre-race breakfast inhibits the effect of caffeine on lipid 
mobilisation. It follows that if the beneficial effect of caffeine in runners is 
dependent solely on caffeine's ability to stimulate lipid mobilisation, then 
ingesting caffeine immediately prior to competition is of little value, as such 
athletes with be carbohydrate-loaded and will have eaten a high CHO meal 
shortly before competition (Hellemans, 1991). Also, during an endurance 
event, athletes ingest a variety of glucose-electrolyte solutions to maintain 
fluid balance when sweat losses are high (Costill and Saltin, 1974), and to 
provide CHO for muscle and nerve energy demands (Erickson et al., 1987). 
These practices elevate serum insulin levels and would be expected to 
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interfere further with the effect of caffeine on lipid mobilisation. This 
argument would appear not to apply to cyclists in whom the carbohydrate-
sparing effect of caffeine seems to occur independently of its effect on serum 
FFA levels. Alternatively, if the ergogenic effect of caffeine is actually via a 
stimulatory effect on the CNS, this argument does not hold. 
The second practical point is the time course of the FFA response to 
caffeine. In most of the studies, exercise commenced 60 minutes after 
caffeine ingestion. Yet it is clear that the peak FFA response to caffeine 
occurs much later, usually 3 to 4 hours after caffeine ingestion (Bellet et al., 
1968, Weir et al., 1987). Thus, if the ergogenic effect of caffeine depends on 
its lipid-mobilising effect, then it would seem logical that exercise should 
only commence when that effect is most pronounced. Alternatively, if the 
ergogenic effect is dependent on a stimulatory effect on the CNS, then 
exercise should commence when caffeine levels are greatest, which would 
appear to be within 3 hours of ingestion (Bellet et al., 1968). 
These findings might explain why many of the previous studies (Costill 
et al., 1978; Ivy et al., 1979; Essig et al., 1980) have failed to show the expected 
degree of serum FFA elevation during exercise after caffeine ingestion. In at 
least two of these studies (Costill et al., 1978; Ivy et al., 1979)r the athletes 
rested for the day before the study, and this may have led to a partial 
carbohydrate-loading effect. Alternatively, exercise may have commenced 
before the serum FFA levels had peaked (Weir et al., 1987). 
With caffeine, athletes can achieve a higher percentage of their V02max 
without inducing metabolic acidosis and therefore perform a greater 
amount or intensity of work. That is, athletes have a higher lactate 
threshold which allows more work to be done at higher levels of lactic acid 
in the blood (Anselme et al., 1992; Costill et al., 1978; Essig et al., 1980; Flinn 
et al., 1990; Ivy et al., 1981; McNaughton, 1987). The alteration of the lactate 
threshold is consistent with the decreased RER since there is less acidity and 
less bicarbonate flushing (Spriet et al., 1992). 
Besides substrate mobilisation, other effects induced by caffeine may 
prove beneficial in endurance activities. These include elevated V02 (Ivy et 
at 1979t direct vasodilation, a reduced activation threshold (Waldeck, 1973t 
increased release of acetylcholine, increased release of Ca2+ ions from the 
sarcoplasmic reticulum, myocardial stimulation, facilitation of gastric 
emptying, diminution of somatic discomfort (Dickinson et al., 1984t and 
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hyperglycaemia (Cheraskin et al., 1967). However, hyperglycaemia should 
be prevented in some endurance sports such as ultramarathon events. 
Regular consumption of glucose during such events is advisable. 
Some convincing evidence indicates that caffeine increases both the 
work output and endurance in long term exercise. The benefits are probably 
due to increased lipolysis and a decreased degradation of muscle glycogen. 
However, reports of studies on caffeine's effect on maximal aerobic power 
(V02max) and time to exhaustion in incremental or graded exercise appear 
to be equivocal. Future studies should attempt to standardise the exercise 
protocol, control for caffeine tolerance and use similar criteria to determine 
the attainment of V02max. 
The general conclusion reached by most sports scientists and many 
athletes, is that caffeine, in spite of the conflicting evidence, has an effect 
during endurance type events but it is difficult to draw firm conclusions 
concerning caffeine's ergogenic potential during incremental work. The 
consensus is that even if caffeine is not ergogenic, taking it can do little 
harm. 
High Intensity Prolonged Exercise Relatively little research has looked 
at the effects of caffeine upon high-intensity prolonged exercise, where the 
relative importance of the different physiological parameters required to 
produce a high level of performance and the physiological causes of fatigue 
can differ from those of endurance work (above) and short-term high-
intensity exercise (below). Caffeine-induced increases in anaerobic exercise 
are likely due to neurologic stimulation, or a reduction in the sensation of 
fatigue. The problem within this area lies however, with the multitude of 
experimental paradigms employed by the researchers. In a recent, well-
controlled experiment, McNaughton (1987) showed that large doses (10 and 
15mg.kg-1) of caffeine given before incremental, exhaustive exercise 
improved performance significantly. 
Using a motorised treadmill, Wiles et al. (1992) investigated the effects 
of the ingestion on 3 grams of caffeinated coffee on: the time taken to run 
1500 metres; the selected speed at which athletes completed a 1 minute 
'finishing burst' at the end of a high-intensity run; and respiratory factors, 
perceived exertion and blood lactate levels during a high intensity 1500 
metre run. The dose used was one that would realistically be ingested by an 
athlete as part of their 'normal' diet without contravening doping 
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regulations. The results showed that caffeine: decreased the time taken to 
run the distance; increased the speed of the 'finishing burst'; and increased 
V02 during the high-intensity run. The study concluded that under the lab 
conditions, the ingestion of caffeinated coffee could enhance the 
performance of sustained high-intensity exercise. 
High Intensity, Short Term Work Although much evidence suggests 
that caffeine may improve endurance performance, questions remain with 
regard its effects on brief, high-intensity exercise and neuromuscular 
function. Availability of fuels is not considered to be a factor for short-term 
intense work tasks. There are three levels at which short-term, high-
intensity exercise performance might be influenced by caffeine: stimulation 
of the CNS; enhancement of neuromuscular transmission; and 
improvement of muscle fibre contractility. 
There appear to be three types of short-term activity that might be 
influenced by caffeine. These include, activities in which speed and timing 
are important, activities which require strength and power, and activities 
which require short-term muscular endurance (Powers & Dodd, 1985). 
Rapid movements Bradycardia and decreased reaction time can occur 
following administration of caffeine (Jacobson & Edgely, 1987), both of 
which could be of benefit in events requiring quick discriminative reactions 
and muscle control. Moreover, subjects feel more alert and active and have 
a decreased sensation of drowsiness (Goldstein et al., 1965, 1969; Smith et al., 
1991). In addition, there can be a reduction in tremor or muscle tension as 
evidenced by altered EMG activity. 
As previously discussed, caffeine stimulates the CNS and facilitates 
neuromuscular transmission. Both of these effects could result in reduction 
in the times required to initiate and complete rapid movements performed 
after receiving an external stimulus. The effects of caffeine on reaction and 
movement times (RT and MT, respectively) reported in the literature have 
been somewhat inconsistent. 
However, despite the apparent inconsistencies, it is generally agreed that 
caffeine doses between 100 and 300mg facilitate RT and MT (Jacobson and 
Edgely, 1987; Lieberman et al., 1987; Silverman & Griffiths, 1992). Dosages 
outside this range tend to have varied or detrimental effects on RT 
(Jacobson and Edgely, 1987; Jacobson & Edwards 1990). Thus, moderate doses 
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of caffeine might improve performance in events that require quick 
reactions and rapid movements. Such events include running and 
swimming sprints. 
Although caffeine may improve RT and MT, it also has negative effects 
on neuromuscular function in that it can impair hand steadiness and 
coordination (Jacobson et al., 1991, Kuznicki & Turner, 1985). This could 
lead to impaired performance in activities such as shooting and archery, 
where hand steadiness is important. 
Maximal static and dynamic muscular contractions It is well 
documented that weight lifters and throwers use caffeine as an ergogenic aid 
(Lopes et al., 1983). Caffeine ingestion increases contractility of electrically 
stimulated muscle in vitro (Huidobro and Amenbar, 1945) and in situ 
(Lopes et al., 1983). However,, when caffeine is used to modify performance 
in large-muscle short-term intense exercise requiring strength and power, 
the studies show essentially no effect (Asmussen & Boje, 1948; Bond et al., 
1986; Butts & Crowell, 1985; Tarnopolsky et al., 1989; Williams, 1991).) 
The study by Lopes et al. (1983) may explain,, in part, these confounding 
results. They investigated the isometric tension developed during ulnar 
nerve stimulation with and without caffeine ingestion. At lower 
frequencies of stimulation, caffeine increased the tension developed while 
at high frequencies or at maximal voluntary contraction it had no effect. 
This suggests that under in vivo conditions,, the sympathetic response to 
work stress is of such a magnitude that it masks the caffeine-induced 
alterations seen in in vitro, in situ,, or resting in vivo studies (Van Handel, 
1983). It is also possible that the homeostatic adjustments in vivo preclude 
effects on contractility seen in vitro or in situ, or that the dose relative to 
the muscle mass involved is too small. 
During sustained, constant-load static exercise, times to exhaustion are 
generally not prolonged nor reduced by caffeine ingestion. Lopes et al. (1983) 
showed that maximal holding time of the adductor pollicus is not altered by 
caffeine. It should be pointed out that quantification of performance during 
sustained static contractions is difficult due to the large individual 
variability in times to exhaustion. 
Dynamic muscular contractions are not only associated with maximal 
force that can be generated by the muscle but also the velocity at which the 
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muscle contracts. The product of these two properties is power output. 
Bond et al. (1986) found that caffeine (5mg.kg~1) had no significant effect on 
power and peak torque generated by the knee flexors and extensors during 
isokinetic exercise. However, Anselme et al. (1992) showed that during 
short-term exercise, caffeine increases maximal anaerobic power. Caffeine 
did not change the highest work load (force). As anaerobic power is the 
product of force and velocity, caffeine ingestion must have increased the 
velocity. Anselme et al. (1992) also reported a higher exercise blood lactate 
concentration with caffeine at the highest exercise load compared to placebo. 
The mechanism for these effects appears to be related to Ca2+ release. This is 
in agreement with Falk et al. (1989) and Collomp et al. (1992). 
Short-term muscular endurance Caffeine might also improve 
performance in sprint and strength types of activities where short-term 
muscular endurance is important (Anselme et al., 1992; Collomp et al., 
1992). Unfortunately fewer studies have investigated this area, but caffeine 
might facilitate Ca2+ exchange at the sarcoplasmic reticulum and increase 
the activity of the sodium potassium pump, better maintaining the muscle 
membrane potential. 
Early work concerning caffeine's effects on short-term muscular 
endurance and work capacity has yielded conflicting results (Foltz et al. 1942, 
1943). More recent work indicates that caffeine has little or no effect on 
short-term muscular endurance and fatigue. During maximal exercise, both 
the rate and magnitude of fatigue are unaffected by caffeine (Collomp et al., 
1992). These authors reported that specific training is necessary to benefit 
from caffeine-induced metabolic adaptations during exercise requiring a 
high anaerobic capacity. Caffeine (250mg) increased swim velocity over 100 
metres in trained subjects but not in untrained subjects. This was possible 
because caffeine activity becomes more effective when intramuscular 
hydrogen ion (H+) accumulation exceeds the intracellular buffering capacity 
(and anaerobic training enhances caffeine's buffedng capacity). 
Summary of Sport Performance Research 
Athletes in a variety of sports reportedly use caffeine before athletic 
competition (Powers & Dodd, 1985). In addition, many governing bodies of 
sport consider caffeine a doping agent. However, the question of whether 
caffeine will improve athletic performance remains largely equivocal. 
Evidence concerning caffeine's effect on long term endurance performance 
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seems to suggest that caffeine may indeed enhance performance (Burke, 
1980). The mechanism appears to be related to the increased availability of 
FFA for muscle substrate, causing a glycogen-sparing effect. The second type 
of activity where caffeine may have positive effects upon sports 
performance is in areas requiring increased alertness1 quick reactions, rapid 
movements, and lowered anxiety levels. This has implications for athletes 
in events such as shooting or archery, where control, concentration, and 
perception are important. However, caffeine might also hinder 
performance in these activities that require hand steadiness. 
Reports concerning caffeine's effect on V02max and performance during 
graded exercise are not in agreement. The reason(s) for these discrepancies 
are not clear. Evidence so far also suggests that use of caffeine as an 
ergogenic aid during exercise in which strength and short-term endurance 
are important has little effect. Acute caffeine ingestion does not seem to 
increase maximal voluntary contractions nor maximal power output nor 
delay fatigue during anaerobic exercise. Thus, use of caffeine to improve 
performance in activities requiring strength and short-term endurance 
(such as weightlifting) seems unwarranted. 
There is still much to be learned about the physiological effects of 
caffeine in humans. Future research should take into account the 
methodological concerns listed previously. 
Health Consequences of Caffeine 
Concerns regarding caffeine's potential adverse health effects, both 
physical and psychological, have long been voiced (Benjamin et al., 1991; 
Wadler & Hainline, 1989) and scientific research abounds on the subject. 
health. Given its wide consumption, the health hazards are few, but 
caffeine has been attacked for a statistical association with various diseases 
(Ashton, 1987; Knowles, 1990). However, fears of a causative role in urinary 
tract and pancreatic cancer (Knowles, 1990), spontaneous abortion, 
teratogenesis, fibrocystic breast disease (Phelps & Phelps, 1988; Davis, 1990), 
have largely been dispelled (Ashton, 1987). Epidemiological evidence 
indicates that caffeine does not increase the incidence of hypertension or 
myocardial infarction (Grossarth-Maticek & Eysenck, 1991; Watson, 1988). 
Excellent reviews on the health consequences of caffeine can be found in 
Curatolo & Robertson (1983), Davis (1990), and Stavric (1988). 
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PART TWO 
THE PRESENT STUDY 
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CHAPTER THREE: RATIONALE FOR THE PRESENT STUDY 
The previous literature review highlights the extent to which studies 
regarding the ergogenic effects of caffeine provide equivocal results. The 
overuse, misuse and abuse of drugs is a major problem in society 
(Weinhold, 1991) and in sport (Waddington & Murphy, 1993t so it is not 
surprising that athletes, of any calibre, are involved. Professional athletes 
found to be using illegal drugs receive a great deal of media attention, but 
little is reported about the much greater number of amateur athletes who 
are involved, unless they are disqualified because of positive drug tests. It is 
impossible to arrive at a precise estimate of the extent of illicit drug use in 
contemporary sport for those who use performance-enhancing drugs 
inevitably seek to do so without being detected. This is because many drugs 
are prohibited by the IOC and other sporting bodies, and because the 
possession of such drugs may also constitute a criminal offence. However, 
an indication of the extent of drug abuse in sport can be derived from urine 
samples analysed by IOC-accredited laboratories. In 1989, 1206 (2.3%) of 52371 
tests returned positive results (Hatherton, 1989). Anabolic steroids and 
diuretics appear to be the most commonly abused drugs in sport. 
Attempts to controt if not eliminate, the illegal use of drugs among 
athletes has gained momentum in recent years. Sports organisations and 
government bodies have attempted to examine the extent of drug use, while 
providing increasingly harsh penalties. However, preoccupation with illicit 
drug use by athletes has diverted the attention from the abuse of licit drugs 
like caffeine. Quantitative research into the extent of caffeine use is by 
athletes is lagging, perhaps due to its ubiquitous nature in our society. Most 
of the accumulated evidence in this area is anecdotal (Anshet 1991). 
Pigeonholing drugs into one category or another has tended to obscure the 
reasons for their abuse, as well as the consequences of that abuse. Even 
categorising drugs as recreationat therapeutic, and performance-enhancing 
suggests that the distinction between categories is well defined, yet 
pharmacological principles indicate otherwise. For example categorising 
caffeine as a recreational drug does not account for its effect of performance. 
Furthermore, this literature review has highlighted that correlations 
between laboratory experiments and competition performance may not be 
close enough to justify banning caffeine solely from results of such tests. 
Consider caffeine's effects on the performance of a cyclist. In the lab setting, 
an athlete who uses caffeine can perform better doing an ergometer cycle to 
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exhaustion. How does that translate to the competitive performance of the 
same cyclist. Is she or he faster? Are his or her tactics and strategies better? 
On the other hand, if perception is a person's reality, does mere belief that a 
drug is ergogenic make it a performance-enhancing drug? Certainly it is an 
issue to be considered when discussing the ergogenicity of caffeine. 
Education is necessary to communicate to all sports medicine 
professionals (as well as athletes and their families and coaches), the realities 
about the benefits and inherent dangers of caffeine. Such information may 
prevent athletes from harming themselves, and assist their sports 
performance. However, to ascertain whether education of athletes is 
warranted (for example, in financial terms) or necessary, it may make more 
sense to address the issue of the extent of caffeine abuse by New Zealand 
athletes. This project was therefore developed to examine the seriousness 
and prevalence of caffeine use by New Zealand athletes. 
Specifically, this study examines the extent of caffeine use by athletes in 
this country and extends a number of research findings from college 
students in the United States to a pool of New Zealand athletes representing 
12 sports. Bradley and Petree (1990) used the expectancies' paradigm 
developed in alcohol research to study caffeine consumption and signs of 
caffeinism in college students. 
Interest in caffeine is motivated by clinical pragmatism. Caffeine 
consumption is ubiquitous in our society, and the potential adverse effects 
of caffeine consumption by athletes have recently become the focus of 
attention. Not only is caffeine intoxication (or caffeinism) a recognised 
'mental disorder', but caffeine is also banned at high levels in the sports 
arena. Moreover, caffeine abuse has been cited as a 'problem' amongst 
athletes but there has been no survey research indicating how much of a 
problem it really is. Caffeine-induced symptoms are of clinical significance 
in and of themselves. Caffeinism can also complicate differential diagnosis 
of other psychiatric disorders, such as anorexia nervosa, a common 
complaint among many female athletes. 
Expectancies regarding caffeine-enhanced performance 
In the present study, the role of expectancies regarding the performance-
enhancing effects of caffeine as a motivational factor was investigated. Since 
the expectancies paradigm from alcohol research was found to be valuable 
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m predicting patterns of problem caffeine consumption among college 
students (Bradley & Petree, 1990), it is potentially useful to extend the 
caffeine expectancy measure to athletes in order to predict the extent of 
caffeine consumption and the occurrence of caffeinism symptoms. 
For many people, caffeine1 s effects reflect its stimulant properties. These 
effects include enhanced psychomotor performance, alertness, and relief of 
fatigue (Jacobson & Edgely, 1987; Rodrigues et al., 1990). There is some 
experimental evidence that college students expect that caffeine will 
enhance their performance. Fillmore and Vogel-Sprott (1992) found that 
placebo effects of caffeine determined college students' mood and 
performance on motor performance, such that those who expected 
enhanced mood or performance experienced the same while those who 
expected impaired mood and performance showed impairments. Page 
(1987) reported that college students who prefer to drink caffeine-containing 
drinks maintain different perceptions about the positive and negative 
consequences of drinking caffeinated drinks from those who do not prefer 
caffeinated drinks. Kirsch and Weixel (1988) observed an inverted-U shaped 
'dose' /response curve in the performance of college students who were 
deceived to believe that they were consuming varying levels of caffeine and 
the occurrence of caffeinism symptoms. The results clearly point to a 
behaviourally potent expectancy of caffeine1s enhancement of performance. 
Gilliland and Andress (1981) studied the relationship between regular 
coffee consumption and the incidence of caffeinism in a nonclinical 
population (159 college students). The survey battery included the State-
Trait Anxiety Inventory and the Beck Depression Scale. The moderate (one 
to five cups per day) to high (five or more cups per day) coffee consumers 
had significantly higher trait anxiety and depression scores than the 
abstainers and the low (less than one cup per day) users. These anxiety 
levels were subclinical, but the authors suggest that they may indicate 
significant and stressful differences in such factors as sleep patterns and 
nervousness. These individuals may be more likely to experience clinical 
levels of anxiety in stressful situations (such as the competitive sports arena) 
than low users. The high consumers also reported significantly higher 
levels of caffeinism symptoms, higher frequencies of psychophysiological 
disorders, and lower academic performances. 
The aim of the present study was to extend the scales of Bradley and 
Petree (1990) and of Page (1987) reflecting college students1 beliefs about 
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caffeine's enhancement of performance to an athlete pool. Based on prior 
findings linking positive caffeine expectancies, high caffeine consumption, 
and negative caffeine outcomes (caffeinism), it was hypothesised that the 
extent of endorsement of personal expectancies of performance-enhancing 
properties of caffeine-containing beverages would be positively related to 
level of caffeine consumption and number of signs of caffeinism reported by 
each subject. A further scale was developed to examine the extent of 
endorsement of expectancies specific to athletic performance. 
In additional analyses, as an analogue to DSM-IIIR classification, subjects 
were divided into those reporting five or more signs of caffeine intoxication 
(caffeinism 'syndrome present') and those reporting fewer than five signs 
(caffeinism 'syndrome absent'). These groups were then compared, 
hypothesising that the syndrome-present group would have significantly 
higher caffeine intake and more performance-enhancement expectancies 
regarding caffeine consumption than the syndrome-absent group. 
A third hypothesis was tested with relation to athletic identity or the 
degree to which an individual identifies with the athlete role. Brewer et al. 
(1993) developed a reliable and valid measure of athletic identity, the 
Athletic Identity Measurement Scale (AIMS). These authors identify a 
number of potential benefits of a strong athletic identity. However there are 
a number of potential costs of strong athletic identity. It is possible that a 
strong athletic identity may prompt individuals to engage in a sport or 
exercise activity to the extent of jeopardising their physical health. 
According to the authors: "excessive training, participating in sport while 
injured, and other such behaviours may in some cases negate the potential 
health/ fitness benefits of a strong athletic identity". Therefore, another aim 
of this study was to examine the relationship between athletic identity and 
the use of caffeine as an ergogenic agent. The hypothesis tested was that 
athletes who identify strongly with the athlete role are more likely to engage 
in drug-taking behaviour than athletes who have a weak athletic identity. 
Furthermore, athletes who compete at a national or international level are 
more likely to have a strong athletic identity than those participating at local 
community or regional level. It is intended that these assumptions would 
identify any differences in caffeine consumption between top class athletes 
and recreational athletes. 
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CHAPTER FOUR: METHODS 
This study tested the assumption that athletes with high levels of 
caffeine consumption have greater expectations of caffeine-enhanced 
performance and more caffeinism symptoms than athletes with low levels 
of caffeine consumption. Chapters 1 and 2 addressed some of the 
physiological and psychological effects of caffeine, and how these might 
affect athletic performance. The design of this study was chosen to replicate 
and extend some research conducted on college students to determine 
whether or not this research might be applied to an athlete sample. This 
study and the research protocol were approved by the University of 
Canterbury Human Ethics Committee. 
Subject Contact 
A letter (Appendix 5) was distributed to 12 National Sports 
Organisations (NSOs) whose addresses appeared on the NSOs Contact 
Address List (Hillary Commission, 1994). This letter was addressed to each 
respective president and requested their assistance with the delivery of 
questionnaires to athletes within their organisation. Only 3 of the NSOs 
were able to offer their assistance (Appendix 6). Canterbury regional 
sporting bodies, which appeared in the Canterbury All-Sports Sports Diary 
(Summer 1994-1995), were contacted and asked to distribute questionnaires 
to athletes of the nine, as yet unaccounted, sports. 
Because of the Privacy Act (1994), athletes were not able to be contacted 
personally. Instead, each distributor received a pack of 30 questionnaires to 
be sent to a representative sample of athletes affiliated to their organisation 
in 1994. Each envelope had been pre-stamped and sealed. All that was 
required of each distributor was to address and mail each of the 30 envelopes 
to a 'representative sample' of athletes. It was requested that they be sent to 
athletes over the age of 18, both male and female, who represented the 
various levels of participation in that sport. 
One week after delivery of the questionnaires to the distributors, they 
were contacted by the researcher to ensure they had made delivery of all 
their allocated envelopes. All 360 questionnaire packs had been mailed out 
or delivered by hand to individual athletes. 
40 
A copy of the questionnaire was provided to each NSO or regional 
representative for their respective organisation's records. Each organisation 
was also provided with summary findings once the results had been 
collated, and interested parties were invited to discuss with the researcher 
anything relating to the study. 
Choice of sports 
There are several sports in which caffeine is not permitted because it is 
considered to artificially assist an athlete's performance. Each sport in this 
study, with the exception of body building, was listed in the Task Force 
Report on the Misuse of Drugs in Sport (Hatherton, 1991) and had a 
recommendation attached to that listing that athletes in these sports be 
tested for stimulants during competition. The 12 sports were chosen 
because they reflected the range of activities in which an athlete's 














Anxiety, reaction time, fine motor coordination 
Pre-competition fat-loss, 1making weight' 
1Making weight', strength and power 
Endurance capacity 
Endurance capacity, anxiety, reaction time 
Strength and power, endurance capacity 
'Making weight', strength and power 
'Making weight\ strength and power 
Endurance capacity, 'making weight' 
Anxiety, reaction time, fine motor coordination 
Endurance capacity 
Caffeine is used by athletes in endurance sports (Powers & Dodd, 1985) 
such as running, cycling, triathlon and rowing. It is also used by athletes 
who must 'make' weight categories, abused for its reported diuretic and 
thermogenic effects. Examples are wrestling, boxing, body building and 
rowing. Participants in these sports often reduce weight at the time of 
weigh-in by dehydration (Clement, 1991). Caffeine ingestion is a means to 
this end, as well as providing purported endurance benefits where there is 
an unwillingness to take calories for fear of not making weight. Body 
builders also require a lean physique for aesthetic purposes, (leanness 
accentuates muscularity). Caffeine may be useful in archery and target 
shooting where decreased reaction time and reduced anxiety are desired. It 
may also be useful in sports requiring strength and power and has been used 
by weightlifters as an ergogenic aid for this purpose (Bond et al., 1986). 
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Procedure 
Subjects for this study were all athletes affiliated to one of 12 regional or 
national sports organisations (Appendix 7). They were informed that they 
would incur no postal expenses, and that individual scores and identities 
would remain confidential. The subjects were also told that their respective 
NSOs would receive a summary of the results at the end of the study, but 
that details of their individual results would not be disclosed. Subjects 
interested in receiving such a summary were invited to request information 
directly from the researcher. Athletes were encouraged to contact the 
researcher for any reason relating to the study. 
Of 360 questionnaires sent out, 185 were returned correctly completed. 
One questionnaire was returned, opened but not filled out. Four additional 
questionnaires were returned unopened, stamped 11Return to Sender" by 
New Zealand Post because they were either insufficiently addressed (by the 
appointed distributor of questionnaires), or because the subject was no 
longer at the address. Two questionnaires were received after the final 
report had gone to print. These subjects noted they had been overseas, 
training and competing, and were very enthusiastic about participating in 
the study. 
Each questionnaire pack contained an introductory letter (Appendix 8) 
and a consent form (Appendix 9). A pre-addressed post-paid envelope was 
included to facilitate return of completed forms to the researcher. Subjects 
were also forwarded the following items: 
Demographic questionnaire 
Caffeinism symptoms questionnaire 
Perceived consequences of caffeine 
Perceived consequences of caffeine in sport 
Sport specific questionnaire 
Athletic Identity Measurement Scale 
Caffeine Intake Questionnaire 
(DEMO-Q; Appendix 10) 
(CAFF-SX; Appendix 11) 
(EP-CAFF.1; Appendix 12) 
(EP-CAFF.2; Appendix 13) 
(SPORT-Q; Appendix 14) 
(AIMS; Appendix 15) 
(T-CAFF; Appendix 16) 
Subject Gifts Subjects were gifted a one-month membership card to Les 
Mills World of Fitness in Christchurch (valued at $45; Appendix 17) 
regardless of whether or not they responded. All subsequent respondents 
were invited to be included in a draw for a 6-month membership at the 
same fitness centre (valued at $295) and were provided with an entry form 
for this purpose (Appendix 18). It was hoped that this would provide an 
incentive for participation. 
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Follow-up No correspondence was entered into with non-respondents 
(those who had not returned their questionnaires within 2 months). The 
feasibility of a second mailing of questionnaires with another stamped 
return-addressed envelope to solicit co-operation, was outside the budget 
constraints of this research. For this reason, a return of just over 50% 
(n=185) had to considered acceptable. 
Consent Athletes were requested to sign and date a consent form to 
comply with Human Ethics regulations. Consent was obtained from 
subjects after informing them in writing that the study involved completing 
a questionnaire that was constructed to assess their caffeine consumption 
and their perception of caffeine's effects upon them. 
Method of Data Collection 
Questionnaires The scales were designed to obtain self-report data on a 
number of variables. Ease and rapidity of questionnaire completion were 
considered in the selection of scales. The scales described below were 
formatted as a questionnaire for subjects to complete. Each questionnaire 
was coded with an individual identifier number, 3 digits long, which 
appeared on every page except the consent form. The questionnaires were 
numbered 001 to 360. 
The first page of the questionnaire was an introductory letter to subjects 
outlining the purpose of the research and requesting their assistance. Once 
the questionnaires had been returned, all consent forms and prize-draw 
entry forms were separated from the questionnaires to preserve each 
subject's anonymity. The entry forms were placed in a sealed box, and a 
winner was drawn on location at Les Mills World of Fitness. The winner 
was notified by mail by a Les Mills employee. 
Scales 
Demographic Questionnaire (DEMO-Q) This questionnaire was 
designed to elicit information about each subject's gender, age, income, 
marital status, ethnic identity and education (Appendix 10). 
Caffeinism Symptoms Questionnaire (CAFFSX) This is a 10-item self-
report measure of subjects' tendencies to experience various signs after 
consuming a caffeinated beverage (Appendix 11). Subjects were asked to rate 
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the extent to which they experienced each symptom on a three-point scale 
(l=never; 2=sometimes; 3=often) when they consumed caffeinated 
beverages. The questionnaire items were based on DSMIII-R 'caffeinism/ 
caffeine intoxication' signs. Previous research showed that a variation of 
this questionnaire (Bradley & Petree, 1990) was sensitive to caffeine. Sample 
items are: "tremor" and "heart palpitations". 
For later analyses, these items were re-coded so that they received no 
point for each symptom they 'never' experienced, and one point for an 
endorsement of a symptom (that is, those they 'sometimes' or 'often' 
experienced). Thus, scores ('CAFFSXl 1') can range from O to 10, with higher 
scores indicating a higher endorsement of caffeinism signs. Then, as an 
analogue to DSMIII-R classification ('INTOX't subjects whose scores were 5 
or greater were identified by the 'caffeinism syndrome present' label. Those 
scoring below 5 were classified as 'caffeinism syndrome absent'. This 
measure was included to assess the extent to which subjects' endorsement of 
caffeinism signs and caffeine intake influenced their responses to the 
'caffeine expectancies' scales (below). Subjects were also asked to rate the 
extent to which they purposely chose to drink non-caffeinated beverages on 
a 4-point scale (l=always, 2=usually, 3=sometimes, 4=rarely), and whether 
the last drink they consumed was caffeinated or caffeine-free. 
Caffeine expectancies (EP-CAFF.1) The rating instrument selected to 
measure athletes' expectations of caffeine was based on a scale used by Page 
(1987), which consists of 26 statements concerning the possible effects of 
caffeine. The statements reflect 10 beliefs about the perceived positive effects 
of drinking caffeinated beverages and 16 beliefs about the perceived negative 
effects of drinking caffeinated beverages (Appendix 12). Sample items are 
"Caffeine helps people stay alert" and "Caffeine makes people nervous and 
anxious". Subjects were asked to indicate their beliefs about the 
characteristics of caffeine by answering 'Yes' (coded as 1), 'No' (coded as 2), or 
'Unsure' (coded as 3). In further analyses the 'unsure' responses were 
ignored, the 'yes' responses re-coded as 1, and the 'no' responses re-coded as 
0. 
Caffeine expectancies m sport (EP-CAFF.2) This measure assesses 
subjects' beliefs about the characteristics of caffeine as they relate to sport. A 
scale was developed using 13 belief statements about fhe perceived effects of 
using caffeine in sports (Appendix 13). The item from the pool was elicited 
from various research findings regarding the potential worth of caffeine as a 
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performance-enhancing drug. Sample items are: "Caffeine can be of benefit 
in sports requiring endurance" and "Very high doses of caffeine can impair 
sports performance". Subjects were asked to indicate whether they 
maintained each belief by answering 'Yes' (coded as 1), 'No' (coded as 2), or 
'Unsure' (coded as 3). In further analyses the 'unsure' responses were 
ignored, the 'yes' responses re-coded as 1, and the 'no' responses re-coded as 
0. 
Sport Specific Questionnaire (SPORT-Q) A sport-specific questionnaire 
(Appendix 14) was designed to elicit information about each subject's sport, 
their main reason for participating, and the number of years they had been 
competitive. Subjects also answered an item requesting information 
regarding their highest level of athletic involvement (classifications were 
local community, regional, national, and international). This questionnaire 
also asked if they had ever used caffeine in sport for its performance-
enhancing effects, even if it meant they risked disqualification as a result of 
a positive urine test being returned after drug-testing. 
Athletic Identity Measurement Scale (AIMS) The rating instrument 
selected to measure the extent to which subjects identified with the athlete 
role was the AIMS (Appendix 15) because it is considered a reliable and valid 
measure of athletic identity (Brewer et al., 1993). It consists of a list of 10 
five-point Likert items anchored by 1 (strongly agree) and 5 (strongly 
disagree). Sample items in the AIMS scale are: "I consider myself an 
athlete" and "I would be very depressed if I was injured and could not 
participate in sport''. The item pool was designed to be representation of the 
social, cognitive, and affective aspects of athletic identity. Scores can range 
from 10 to 50, with lower scores reflecting a stronger identification with the 
athlete role. For the purpose of this study, subjects whose scores fell below 
25 were classified as high in Athletic Identity, whereas those equal to or 
above the 25 were operationally defined as low in Athletic Identity. 
Daily Caffeine Intake Questionnaire (TCAFF) Also included among the 
instruments was a caffeine intake questionnaire (Appendix 16). Average 
daily total caffeine consumption (in milligrams) was calculated as the sum 
of caffeine per day using estimates by various authors on the caffeine 
content of commonly consumed beverages (Table 1). These estimates are 
known to vary widely, however, according to the brand and brewing 
method of each beverage. Note that the 'Average' value reported in said 
table was used to ascertain caffeine consumption. 
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Although consumption of the most common caffeine-containing 
substances was monitored (for example, coffee, tea, colas, chocolate, NoDoz, 
and other drugs), coffee and tea overwhelmingly accounted for the majority 
of caffeine ingested by any one subject, with colas and chocolate making up 
the balance. Interestingly, no drugs contributed to the caffeine intake of any 
of the subjects. The level of caffeine consumption ('TCAFF') was coded 
according to the following criteria: 
0 - 99mg daily caffeine intake was coded as 0 
100 - 199mg daily caffeine intake was coded as 1 
200 - 299mg daily caffeine intake was coded as 2 
300 - 399mg daily caffeine intake was coded as 3 
400 - 499mg daily caffeine intake was coded as 4 
500 - 599mg daily caffeine intake was coded as 5 
600 - 699mg daily caffeine intake was coded as 6 
700 - 799mg daily caffeine intake was coded as 7 
800 - 899mg daily caffeine intake was coded as 8 
900 - 999mg daily caffeine intake was coded as 9 
above 1000mg daily caffeine intake was coded as 10 
In further analyses level of caffeine consumption was further defined. 
Subjects were assigned to three groups ('INTAKE') based on their average 
daily caffeine consumption. Low caffeine intake was operationally defined 
as less than or equal to 200mg per day; moderate caffeine intake was defined 
as between 200 and 400mg per day; and high caffeine intake was defined as 
greater than 400mg per day. 
Dependent Variables The dependent variables were each calculated as 
follows: A score was obtained based on the number of positive EP-CAFF. l 
scale items endorsed by each subject. In order to replicate the study of 
Bradley and Petree (1990) the dependent variable of the first hypothesis is 
confined to analysis of the following 6 scale items: 13, 15, 19, 23, 25, 26. The 
contents of this scale ('EXPECT' motives) defines caffeine use in terms of the 
expected 'functions' which this drug is intended by the user to serve. These 
functions reflect caffeine's central nervous system stimulating effects. 
In order to replicate the study of Page (1987), a score ('POSITIVE') was 
obtained based on the total number of positive EP-CAFF.1 scale items 
endorsed by subjects. This included the following items: 1, 3, 4, 5, 13, 15, 19, 
23, 25, 26. Another score ('NEGATIVE') was obtained based on the total 
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number of negative EP-CAFF.l scale items endorsed: 2, 6, 7, 8, 9, 10, 11, 12, 
14, 16, 17, 18, 20,211 22, 24. These item numbers are listed in Appendix 20. 
In order to examine sporting enhancement beliefs~ a score ('ENHANCE1 ) 
was obtained based on the total number of positive EP-CAFF.2 scale items: 11 
21 31 4, 5, 61 71 81 91 101 11 and 13. The individual items are listed in Appendix 
21. The twelfth item was not included in the 'ENHANCE1 score because it 
was coded in the opposite direction to the other statements. 
Subjects were currently competing in one of twelve sports (in order of 
descending frequency): fencing (11.4%; n=21); cycling (10.8%; n=20); rowing 
(10.3%; n=l9); triathlon(9.7%; n=18); body building (9.7%; n=18); wrestling 
(8.6%; n=16); athletics (8.6%; n=16); power-lifting (8.1 %; n=15); archery 
(8.1 %; n=15); ice-racing (7.0%; n=13); shooting (6.5%; n=12); and boxing 
(1.1 %; n=2). Data from the male and female subjects and across sports were 
combined for most analyses after ANOV A revealed no significant 
differences for gender on either caffeine intake or sport (see Results Section). 
Data Analysis 
The data were analysed using the Statistical Package for the Social 
Sciences (SPSS for Windows) by descriptive statistics1 analysis of variance 
(ANOVAt multivariate analysis of variance (MANOVAt multiple 
regression and chi-square analysis1 depending on the variable distribution 
and research question. For all statistical tests1 effects were considered 
significant for p ~ .05. 
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CHAPTER FIVE: RESULTS 
Introduction The aim of this study was to determine caffeine 
consumption1 expectations of caffeine-enhanced performance and 
caffeinism symptoms in a sample of New Zealand athletes. It was also 
considered important to measure the extent to which subjects who identify 
strongly with the athlete role engage in drug-taking behaviour, specifically 
caffeine 'abuse1 • This chapter describes the characteristics of the sample, and 
presents the results of the data analyses. 
Demographic Characteristics A total of 185 subjects completed the 
questionnaire and all of these were considered valid. Subjects were 
excluded from analyses when data were missing on the variables concerned. 
High caffeine consumers (>400mg per day) accounted for 8.6% (n=16) of 
returns; 23.8% (n=44) were moderate caffeine consumers (200 to 400mg); and 
67.6% (n=125) were low caffeine consumers (<200mg per day). Athletes who 
identified strongly with the athlete role made up for 51.4% of the sample. 
Age Almost half of the subjects (45.9%) were aged between 18 and 25 
years. 17.3% represented the 26 to 30 age-group1 12.4% were aged 31 to 351 
7.6% were aged 36 to 401 9.2% were aged 41 to 45, 4.9% were aged 46 to 50, and 
1.6% were over the age of 50. Two subjects did not divulge their ages. Sixty 
males (32.4%) and 124 females (67%) responded to the questionnaire. 
Education In terms of the highest education level achieved1 15.1 % had 
gained school certificate1 25.4% had achieved sixth form certificate or 
university entrance1 14% had completed Form 71 19.5% had a university 
qualification1 13.5% had a trade certificate, and 12.4% declined to answer. 
Income The annual personal incomes reported by subjects are as 
follows: 31.4% earned less than $100001 20.5% earned between $20000 and 
$300001 21.1 % earned between $30000 and $400001 12.4% earned between 
$40000 and $500001 5.4% earned between $40000 and $500001 and 7.6% earned 
over $50000. Those who did not provide personal financial information 
constituted 1.6% of the sample. The following are the statistics reported for 
annual household incomes: 7% earned less than $100001 5.4% earned 
between $20000 and $300001 15.7% earned between $30000 and $400001 17.8% 
earned between $40000 and $500001 15.1 % earned between $40000 and $50000, 
and 31.9% earned over $50000. Seven percent did not provide household 
financial information. 
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Relationship and Family Status The majority (58.7%) described 
themselves as single, 28.1 % were married, 7.6% were in de facto 
relationships, 5.4% were divorced or separated. One subject (.5%) did not 
disclose relationship information. Most subjects (73.0%) had no children, 
3.2% had one child, 10.3% had two children, 9.2% had 3 children, and 3.2% 
had four or more children. Two subjects declined to comment. 
Ethnic Origin When asked to describe their ethnic origin 93% classified 
themselves as New Zealand European, 1.1 % as New Zealand Maori, 1.1 % as 
Polynesian, and 0.5% as Asian. A total of 3.8% classified themselves as 
identifying with an 'other' ethnic origin, and one respondent did not 
complete this section of the questionnaire. 
Supplementary Correlations and ANOVAs No significant correlations 
were found between the demographic variables (income, education, 
relationship status, number of children, and ethnic origin) and caffeinism 
symptoms or caffeine intake. However, analysis of variance (ANOVA) 
revealed a significant difference between caffeine intake ('TCAFF') groups 
on the basis of age [F(5,178)=4.021, p<.01]. Analysis of variance revealed a 
nonsignificant difference between caffeine intake groups on the basis of 
gender [F(l,182)=.04, p=.84 (n.s)], and a significant F-ratio was revealed for 
the effect of gender on 1CAFFSX1l' (number of caffeinism symptoms 
endorsed) [F(l,184)=5.70, p<.05], with females endorsing more signs than 
males. No significant differences were found for the effect of gender intake 
on sport [F(l, 183)=.90, p=.34 (n.s)], nor of sport on caffeine intake CTCAFF') 
[F(ll,183)=1.52, p=.13 (n.s)]. 
Internal Consistency The internal consistency, using Cronbach1 s 
coefficient alpha, of the respective expectancies scales are as follows: 
~XPECT1 (.6872), 'POSITIVE' (.6950), 'NEGATIVE' (.9332), 'ENHANCE1 
(.8495), 1AIMS1 (.8689) and 'CAFFSX1l 1 (.7880). These reliability coefficients 
were judged it to be adequate for the present study, that is, all alphas 
reached at least the .05 level of significance. 
Relationship between Caffeine Consumption and Caffeinism Symptoms 
Figures 5 shows the distribution of subjects by their average daily caffeine 
intake. When subjects were further classified into three caffeine intake 
groups, 35 subjects reported being 'high' daily caffeine consumers, 79 were 
'moderate1 consumers, and 70 comprised the 'low' consumption group. 
Distribution of Subjects by 
Caffeine Consumption 
ABCDEFGH I J K 
Daily Caffeine Intake (mg} 
Figure 5 - Distribution of subjects by their average daily 
total caffeine consumption. Key: A 0-99, B 100-199, C 200-
299, D 300-399, E 400-499, F 500-599, G 600-699, H 700-799 I 
800-899, J 900-999, K Above 1000 milligrams. 
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Figure 6 displays the distribution of subjects by the number of caffeinism 
signs they endorse. Subjects classified as 'caffeinism syndrome present' (that 
is, those endorsing 5 or more of the DSMIII-R symptoms) number 46, and 
those labelled as 'caffeinism syndrome absent' number 139. 
>, 
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Number of signs endorsed 
Figure 6 - Distribution of subjects by the number of caffeinism 
symptoms endorsed by each. Those endorsing 5 or less are classified 
as caffeinism syndrome absent, those endorsing more than five are 
classified as caffeinism syndrome present. 
Caffeinism data The association between the amount of caffeine 
consumed ('INTAKE') and the caffeinism status of subjects ('INTOX') is 
presented in Table 5. The caffeinism syndrome present group was 
composed of 63% low caffeine consumers, 26.1 % moderate caffeine 
consumers, and 10.9% high caffeine consumers. The constitution of the 
syndrome absent group is as follows: 68.4% are low caffeine consumers, 
23.5% are moderate caffeine consumers, and 74.7% are high caffeine 
consumers. The three levels of caffeine consumption ('INTAKE') were 
subdivided by the caffeinism status of subjects ('INTOX'). 3 X 2 chi-square 
(X2) analysis [x2(2)81)=.54, p<.50 (n.s)] yielded a non-significant contingency 
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coefficient (p=.76). This indicates that subjects' caffeine intakes and their 
caffeinism status (present or absent) are not significantly related. 
Tables 
Distribution of Subjects in each Caffeine Group b 
To explore these variables further, an analysis of the variance (using the 
Pillais statistic) of mean caffeinism scores ('CAFFSXl 1') across the three 
caffeine groups was conducted. The results indicated that the severity of 
caffeinism scores did not change significantly with increased caffeine 
consumption ('INTAKE') [F(2,184)=1.28,, p=.192 (n.s)]. However,, when the 
caffeine consumptions were not grouped (into high, moderate and low) but 
were entered as the initial values of 'TCAFF' (as seen in figure 5), ANOVA 
reached the .001 level of significance [F(l0,184)=16.318,, p<.001]. These 
results indicate that,, on the basis of mean caffeine consumption, there is a 
significant difference between caffeinism scores. 
Those who endorsed five or more signs of caffeinism ('INTOX') were 
compared to those who endorsed less than five symptoms to determine the 
significance of the various 'CAFFSX' questionnarie items. A multivariate 
analysis of variance of the 10 symptoms was significant [F(9,181) = 64.543, 
p<.001]. Discriminant analysis (univariate F-tests with (1,180) d.f.) indicate 
that those who were given the 'caffeinism present' label were more likely to 
report restlessness,, nervousness, insomnia, diuresis, gastrointestinal 
disturbance, muscle twitching, impaired thought and speech, pounding 
heart, and periods of inexhaustibility (p<.001), and flushed face (p<.05). 
Effect of caffeine consumption on performance-enhancing expectancies 
The first hypothesis tested - that the extent of endorsement of personal 
expectancies about performance-enhancing properties of caffeine would be 
positively related to level of caffeine consumption and number of signs of 
caffeinism - was explored with the following results. 
51 
A stepwise multiple regression analysis was performed using the 
caffeine enhanced performance scale score ('EXPECT') and caffeine intake 
('INTAKE') as independent variables, and the number of caffeinism 
symptoms ('CAFFSX1l1) as the dependent variable. Results of this analysis 
are shown in Table 6. 'EXPECT' and 'INTAKE' yielded a multiple R of .225 
[F(1J84) = 1.86, p=.163 (n.s)]. The results of this test are not statistically 
significant indicating that there is no effect of expectancy score and caffeine 
consumption on the number of caffeinism symptoms endorsed by subjects. 
The null hypothesis can not be rejected at this low level of significance. 
Table6 
Results of Stepwise Multiple Regression Using 
Number of Caffeinism Signs as the Dependent Variable 
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The second hypothesis - that the syndrome present group would have 
significantly higher intake and more performance enhancement 
expectancies that the syndrome absent group - was tested statistically by use 
of a complex x,2 test comparing the 'EXPECT' score to caffeine intake 
'INTAKE' and ANOVA comparing the effects of 'INTAKE' and 'INTOX' 
on 'EXPECT'. 
The x,2 analysis of the relationship between the 'EXPECT' score 
(expectancy of CNS effects) and 'INTAKE' (caffeine consumption group) 
yielded a nonsignificant Pearson chi-square probability (p=.855). A 
multifactorial (3x2) test of significance was performed using the 'EXPECT' 
score as the dependent variable and 'INTAKE' and 'INTOX' as independent 
variables (Table 7). A significant F-ratio was revealed [F(3,182)=3.84, p<.05]. 
Most of the variance was attributable to 'INTOX' [F(l,182)=8.66, p=.01] rather 
than 'INTAKE' [F(2,182)=1.08, p=.35 (n.s)]. This indicates an association 
between caffeinism status and expectancy score, such that caffeinism status, 
but not the level of caffeine intake, can be used to predict expectancy scores 
(at least on the scale of caffeine's CNS stimulating effects). The null 
hypothesis can be rejected on the basis of these results. 
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Table7 
ANOVA: Change in EXPECT score with INTAKE and INTOX 
ANOV As assessing the effects of 'INTAKE' and 'INTOX' on 'POSITIVE', 
'NEGATIVE', and 'ENHANCE' scores were systematically performed with 
the following results (Tables 8 to 10). Significant main effects were found for 
'NEGATIVE' (p<.05) and 'ENHANCE' (p<.01) but not for 'POSITIVE' (p=.22). 
Most of the variance in the 'NEGATIVE' and 'ENHANCE' scores is 
attributable to caffeinism status ('INTOX') rather than caffeine intake. These 
statistics indicate that the 'NEGATIVE' expectancies scores and the 
'ENHANCE' expectancies scores, respectively, are associated with caffeinism 
status, but not caffeine consumption. The 'POSITIVE' scale scores share no 
association with either 'INTAKE' or 'INTOX'. 
Tables 
e in POSITIVE score with INT AKE and INTOX 
Table 9 
e in NEGATIVE score with INTAKE and INTOX 
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Table 10 
ANOVA: Change in ENHANCE score with INTAKE and INTOX 
A further multifactorial (3x2x2) ANOV A (Table 11) was conducted using 
the number of caffeinism symptoms ('CAFFSXl 1') as the dependent 
variable, and 'INTAKE' (high, moderate or lowt 'CHOOSE' (the extent to 
which athletes purposely choose non-caffeinated beverages, rated as always 
or usually versus sometimes or never) and 'CAFUSER' (whether or not 
subjects use caffeine as a performance-enhancing drug in sport) as the 
independent variables. A significant main effect was obtained (p<.001), with 
'INTAKE' being the main source of variation. 
These results indicate that, on the basis of the number of caffeinism 
symptoms endorsed, there is a significant difference between those in each 
caffeine group [F(2,183)=19.25,p<.001], and between those who use caffeine as 
a performance enhancing drug versus those who do not 
[F(l,183)=4.46,p<.05], and between those who usually drink caffeinated 
beverages versus those who do not [F(l,183)=4.16,p<.05]. A number of two-
way interactions (Table 11) are also significant. 
Table 11 
ANOV A: Chan e in CAFFSXll with INTAKE, CHOOSE & CAFUSER 
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The extent to which athletes purposely choose ('CHOOSE') non-
caffeinated beverages when selecting something to drink is as follows: 6 
(3.2%) always, 25 (13.5%) usually, 70 (37.8%) sometimes, and 84 (45.4%) 
never. When asked whether their last drink was caffeinated or caffeine-free, 
74 (40%) of the sample stated caffeinated, 105 (56.8%) stated caffeine-free, and 
6 (3.2%) did not know. 
Those who always or usually select non-caffeinated beverages (16.7%), 
were compared to those who rarely or never select caffeinated beverages 
(83.2%) to determine whether the two groups maintained different 
perceptions about the consequences of drinking caffeinated beverages. 
Multivariate analyses of variance on the 'EXPECT' scale score, the 
'POSITIVE' scale score, the 'NEGATIVE' scale score, and the 'ENHANCE' 
scale score, all yielded non-significant F-ratios (p=.48, p=.95, p=.40, and p=.48 
respectively). Discriminant analyses on individual scale items were 
therefore inconsequential. These results indicate that perceived 
psychoactive-, positive-, negative- and sports performance enhancing-
effects are not strong indicators for selecting a beverage by those who prefer 
caffeinated beverages. 
Regarding the 'PED' item, 26.5% of the sample believe caffeine enhances 
performance in their sport, 24.3% answered 1no1 1 13.5% believe it sometimes 
enhances performance, and 35.7% did not know whether caffeine is or is not 
a performance-enhancing drug. 
When confronted with the question, "Do you consume caffeine for its 
performance enhancing effects?", 75.7% of the sample (n=l40) claimed they 
had never used caffeine as a performance enhancing drug. The other 24.3% 
(n=45) admitted to using caffeine as an ergogenic aid. Of the 45 athletes who 
reported using caffeine as a performance enhancing drug, 7 (3.6%) had been 
using it for more than 5 years, 3 (1.6%) for between 4 and 5 years, 3 (1.6%) for 
between 3 and 4 years, 11 (5.9%) for between 2 and 3 years, 10 (5.4%) for 
between 1 and 2 years, and 12 (6.5%) athletes had been using it for less than 
one year. When asked whether they had ever intentionally used caffeine in 
competition knowing that they risked disqualification if a urine test showed 
high levels of caffeine, 17 (9.2%) of the entire sample responded 'Yes'. The 
sports with the greatest frequencies of caffeine 'users' were cycling and 
bodybuilding. Of the 12 bodybuilders using caffeine, only 2 had competed 
internationally, whereas all 13 of the cyclists who used caffeine as a PED 
were New Zealand representatives. 
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A number of ANOV As were performed comparing athletes who used 
caffeine as a performance enhancing drug ('CAFUSER1 ) with those who did 
not, to determine whether the two groups held different beliefs about 
caffeine. The scores of the groups on the respective expectancy scales were 
all significantly different ['EXPECT': F(l,184)=22.148, p<.001; 'POSITIVE': 
F(l,184)=27.452, p<.001; 'NEGATIVE': F(l,184)=10.585, p<.05; and 
'ENHANCE': F(l,184)=23.94, p<.001]. These results indicate that athletes 
who use cafffeine as an ergogenic agent maintain different expectancies 
regarding caffeine's effects, than athletes who do not use caffeine as a 
performance enhancing drug. A further ANOV A revealed a non-
significant difference between athletes who use caffeine as a PED and those 
who did not, on caffeine intake [F(l,184)=.926, p=.398 (n.s)]. 
A significant correlation coefficient was obtained for 'PED' (whether or 
not a subject believes caffeine is a performance enhancing drug) and 
'ENHANCE1 (the score on the scale that measures beliefs about the 
performance enhancing effects of caffeine in sport; p<.001). Similarly, 
significant correlation coefficients were reported for 'PED' and 'CAFUSER' 
(p<.001) and for 'CAFUSER' and 'ENHANCE' (p<.001). These results 
indicated that three significant relationships exist: 
1. A relationship exists between athletes' beliefs in caffeine as a PED, and 
their expectations regarding caffeine-enhanced performance in sport; 
2. An association exists between athletes' beliefs of caffeine as a PED, and 
their use of caffeine as a PED; 
3. Athletes' use of caffeine as a PED and their expectancies regarding 
caffeine-enhanced performance in sport are related. 
To corroborate this finding, an ANOVA was performed. A significant 
difference was obtained between those who believe caffeine is a 'PED' and 
those who do not, on their use of caffeine ('CAFUSER') as an ergogenic 
agent [F(l,118)=40.600, p<.001]. The effect of gender, as a co-variate in this 
analysis, was not significant (p=.723). This indicates that, on the basis of 
belief in caffeine as a PED (but not on the basis of gender), there is a 
significant difference between athletes who use caffeine as an ergogenic 
agent, and those who do not. 
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General Athlete Data In terms of the number of hours athletes spent 
training every week, 17.8% reported training more than 21 hours per week, 
24.9% reported spending between 14 and 21 hours on their training, 34.1 % 
spent between 7 and 14 hours training, and 23.2% spent less than 7 hours 
training per week. Over half of the sample (54.1 %) had been involved in 
their sports for more than 6 years, 29.2% had been participating for between 
3 and 6 years, and 16.8% had been active for less than 3 years. No further 
analyses on these data were undertaken. 
Comparison of Athletic Identity and Sporting Achievement Descriptive 
statistics for the individual AIMS items are presented in Table 12. Subjects' 
scores (µ=26.33/ cr=7.75) on the Athletic Identity Measurement Scale (Figure 
7) were compared with their level of athletic participation (Table 13) with 
the following results. 51.4% of the sample identified strongly with the 
athlete role, scoring less than 25 on the AIMS. Corroboration with 
achievement data indicates that 48.6% had represented New Zealand and 
30.3% competed at national level. Those whose highest level of 
participation was the regional level accounted for 13.0% of the sample, 
while 8.1 % of respondents had only competed at local community level. 
The majority of participants who had a strong athletic identity had 
competed at national or international level. 
Table 12 
tive Statistics for the AIMS Items 
a 
Note. l=strongly agree, S=strongly disagree. 
Distribution of Subjects by AIMS Score 
6 11 16 21 26 31 36 41 46 
AIMS Score 
Figure 7 - Distribution of Subjects by Aims Score 
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Analysis of the variance between athlete's scores (Table 14) on the AIMS 
and their highest level of participation (Local/Regional/National or 
International) was significant [F(4, 183)=4.05, p<.01]. When levels of 
participation were combined (Local/Regional versus National/ 
International) the ANOV A result (Table 15) was also significant 
[F(l,182)=12.18,p<.01]. When gender was included in the analysis, it yielded 
a nonsignificant main effect [F(l,182)=1.36, p=.24]. When athletes were 
grouped differently (Local/Regional/National versus International) the 
result reached a higher level of significance [F(1 1 182)=16.31, p<.001]. 
Table 13 
Agreement between Athletic Identity & Level of Participation 
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Table 14 
e in AIMS Score with GRADE and GENDER 
Reliability and Construct Validity of the AIMS The reliability coefficient 
of the AIMS, using Cronbach' s alpha, reached the .01 level of significance. 
Each of the reported ANOV As provide support for the validity of AIMS. 
Most important for construct validity was the significant main effect for 
level of athletic involvement ('GRADE') on AIMS [F(3, 182)=3.690, p<.05]. 
As shown in Table 13, AIMS scores increased with level of athletic 
involvement. Further analyses comparing highest level of participation 
('NATIONAL and INTERNATIONAL' versus others and 'NZREP' versus 
others) on the classification of strong athletic identity versus weak athletic 
identity (Tables 16 and 17 respectively) produced significant F-ratios. The 
main effect of gender on Athletic Identity was not statistically significant in 
either analysis [F(l,182)=.090, p=.765(n.s) and F(l,182)=2.787, p=.097(n.s) 
respectively]. 
Table 15 
ANOV A: Change in AIMS Score by Elite and Gender (n=183) 
Table 16 
Identity Present or Absent b 
Table 17 
ANOV A: Identity Present or Absent and NZ REP (n=183) 
Table 18 
Distribution of Subjects Accordin to Gender and Level of Participation 
. j 
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Subjects main 'MOTIVE' for participating in sport and their· highest 
level of participation were compared (Table 19). Chi-square analysis of this 
relationship revealed a significant Pearson chi-square probability (p<.001) for 
181 subjects. Four of the subjects had missing values and were not included 
in this analysis. The value of phi (~=.539) indicates rejection of the null 
hypothesis at .001 level of significance. 
Table 19 
Distribution of Subjects by Motive for Participation and 
Hi hest Level of Participation 
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The third hypothesis tested - that athletes identifying strongly with the 
athlete role would be more likely to use caffeine as a PED - was tested 
statistically by use of a 2x2 X2 test comparing the athlete role and use of 
caffeine as an ergogenic drug [x2(1,184)=11.502, p<.001]. Table 20 shows the 
cell frequencies in this equation. The result of this test indicates that the use 
of caffeine as a PED, and athletic identity are significantly related. The phi 
statistic for this relationship (~=.249) provides an indicator of the degree of 
relationship between the two variables. The null hypothesis can be rejected 
at this high level of significance. 
Table 20 
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ANOV A revealed a significant difference between mean AIMS score 
and CAFUSER [F(l,183)=17.857, p<.001]. This can be taken to indicate that, on 
the basis of the AIMS scores (extent to which a subject identifies with the 
athlete role), there is a significant difference between those who use caffeine 
as an ergogenic agent and those who do not use caffeine in such a manner. 
The final table to the results section (Table 21) shows the proportion of 
respondents in each of the twelve sports, the highest grade achieved, 
whether or not they believe caffeine is a PED, the extent to which they use 
caffeine as a PED in sport, and their caffeinism status. 
Chi-square analysis of the relationship between athlete's sport and their 
use of caffeine as a PED yielded a significant Pearson chi-square probability 
(p<.001). Similarly, chi-square analysis of the relationship between athletes 
sport and their belief of caffeine's ability to enhance sport performance 
yielded a significant Pearson chi-square probability (p<.001). Clearly, these 
data warrant further investigation. Chi-square analysis of the relationship 
between sport and caffeinism status yielded a non-significant Pearson chi-
square probability (p=.453). 
Table21 
General Athlete Data 
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CHAPTER SIX: DISCUSSION 
Implications of the Results 
Caffeinism Signs A substantial portion (25.3%) of this sample reported 5 
or more 'caffeinism' signs. This finding, while clearly not a clinical 
appraisal of caffeinism, bolsters the importance of studying this syndrome in 
athlete samples where the ubiquitous use of caffeine is ingrained in the 
culture. 
Caffeinism Severity and Caffeine Intake It has been suggested that 
quantity of caffeine consumed is strongly associated with caffeinism. This 
hypothesis implies that groups containing subjects with high levels of 
caffeinism should contain disproportionate numbers of high caffeine 
consumers. This hypotheses was tested on a sample of athletes. That the 
chi-square test comparing caffeine intake and caffeinism status was not 
significant, was surprising. Bradley and Petree (1990) revealed a significant 
association between the two. However, the divergent results between that 
and the present study could reflect methodological differences. Another 
possibility relates to individual sensitivity to the drug and a person's 
'normal' intake. These possibilities are elaborated below. 
Caffeine Expectancies The literature reviewed in chapters 1 and 2 
indicates that caffeine has many physiological effects. Furthermore 
expectations play a part in the effects that caffeine exerts (Fillmore & Vogel-
Sprott, 1992). The aim of the present study was to develop a scale (from 
findings of previous research) reflecting beliefs about caffeine's effects 
(Bradley & Petree, 1990; Page, 1987). Based on prior findings linking positive 
caffeine expectancies, high caffeine consumption, and negative caffeine-use 
outcomes, it was hypothesised that the extent of endorsement of personal 
expectancies of performance-enhancing properties of caffeine-containing 
beverages would be positively related to level of caffeine consumption and 
number of signs of caffeinism reported by each subject. 
The results of this study do not suggest that expectancies regarding 
caffeine's CNS stimulating effects predict both increased caffeine 
consumption and problem outcomes (caffeinism). While the present study 
found an agreement between caffeinism status and expectancy scores, there 
was oddly no agreement between caffeinism status and caffeine intake. This 
may, in part, be due to individual sensitivity or habituation. For example, 
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those who do not usually drink caffeine, or who are sensitive to it, may 
experience 5 symptoms all at once when they do consume this drug (such as, 
insomnia, shaky hands, nervousness, gastrointestinal disturbance, and 
palpitations). These subjects can hardly be diagnosed with "caffeinism". By 
the same token, subjects who genuinely suffer from "caffeinism" may not 
experience the symptoms when they use caffeine, but may use caffeine to 
alleviate the same symptoms which may be brought about when an 
habitual consumer suddenly abstains (a withdrawal response). 
The non-significant correlations observed between endorsement of 
performance-enhancement motives, caffeinism symptoms and caffeine 
consumption are not consistent with experimental findings that college 
students who drink coffee expect it will aid their psychomotor performance 
(Kirsch & Weixel, 1988). The questionnaire survey by Bradley and Petree 
(1990) also revealed an association between the use of caffeine for the 
'common sense' purpose of exploiting its central nervous system 
stimulating effects ('EXPECT' motives) and reported levels of both caffeine 
intake and DSM-III caffeinism symptoms. Moreover, they found that 
syndrome-present subjects endorsed more expectancy items and consumed 
more caffeine than syndrome absent subjects. Again, the discrepancies 
between the studies could be due to the different subject pool (students 
versus athletes), research protocol differences, or methodological flaws in 
the present research. 
The present study has revealed no association between expectancies of 
performance enhancement and caffeine intake. However, associations 
between the caffeinism status of subjects and their psychoactive, negative, 
and sporting enhancement expectancies were found. Whereas caffeine 
intake and caffeinism status were not good predictors of the expectancy score 
(involving caffeine's CNS stimulating effects), an athlete's use of caffeine as 
a PED in sport was a good predictor of the same expectancy score. 
Furthermore, while CNS-stimulating expectancies were not a good 
predictor of the extent of caffeine consumption and the occurrence of 
caffeinism symptoms, the sport performance-enhancing expectancies 
measure was more useful in predicting caffeine consumption and 
caffeinism symptoms. The results also suggest that expectancies regarding 
sport performance enhancing effects ('ENHANCE' motives) are especially 
useful in predicting the use of caffeine as a performance enhancing drug in 
sport. These findings provide some support for the notion that sporting 
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expectancies can be valuable in predicting patterns of problem caffeine 
consumption. It must be noted that a liberty has being taken in describing 
caffeine consumption as problematic. For the purpose of this discussion the 
operational definition of problem caffeine consumption is met when the 
number of DSMIII-R "caffeinism" symptoms endorsed by a subject exceeds 
four. Caffeine consumption may also be seen as a problem by some people 
when it is being used (abused or misused?) for it performance-enhancing 
effects in sport. 
In additional analyses1 those who always or usually select non-
caffeinated beverages were compared to those who rarely or never select 
caffeinated beverages to determine if they maintained different perceptions 
about the consequences of drinking caffeinated beverages. Multivariate 
analyses of the 10 positive statements and the 16 negative statements 
respectively1 were non-significant. That is1 the perceived and/ or derived 
psychoactive effects (that is1 gives one more energy1 helps one to feel better1 
are relaxing) are not strong motivators for selecting a beverage by those who 
prefer caffeinated beverages. Similarly1 those who usually select non-
caffeinated beverages do not appear to refrain from caffeine-containing 
beverages because of the potential health implications and concerns1 but for 
some1 unknown1 reason. These findings are in contrast to those of Page 
(1987) who found that subjects who rarely drink caffeinated beverages are 
more likely to have negative expectancies regarding caffeine1 s effects (that is1 
caffeine: is habit-forming; makes people more irritable1 nervous1 anxious 
and jittery; and1 causes ulcers1 headaches1 kidney and bladder damage1 high 
blood pressure and stomach upsets). Furthermore1 Page (1987) found that 
people who do consume caffeinated beverages are more likely to perceive 
that these drinks give people more energy1 help them relax1 help them feel 
better1 taste good1 and are refreshing. 
Despite1 the results of the present study conflicting with Page1s finding 
that the above perceived and/ or derived effects of caffeine are strong 
motivators for either abstaining from or selecting a caffeinated beverage1 the 
scale was still of some worth. That is1 the positive effects listed above do 
appear to be strong motivators for those who use caffeine as a performance 
enhancing drug in sport. Even more significant is the finding that the 
perceived and/ or derived sport performance enhancing effects of caffeine 
are strong motivators to using the drug during competition. 
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It is axiomatic that the findings of this study are not consistent with the 
behavioural expectancies which seem to have developed in our society. A 
cup of coffee is used to 'get going' in the morning. Over-the-counter caffeine 
tablets are sold to assist in combating fatigue, and decaffeinated coffee exists 
for those who experience nervousness or tension from caffeine. Virtually 
everyone has been exposed to information that would create the expectancy 
that caffeine is associated with symptoms such as reduction of fatigue or the 
production of nervousness. 
Given the opportunity to develop these expectancies, it is interesting 
that the expectancy effect was found only on selected scales. Further 
discriminant analyses are required to reveal which individual items on 
these scales are associated with a stronger expectancy effect. In the interim, 
Appendix 20 and 21 give some indication of the particular weightings 
ascribed to each item on the EP.CAFF-1 and EP.CAFF-2 scales respectively. 
The Caffeinism Symptoms Questionnaire consisted of symptoms previously 
reported as being experienced by caffeine consumers which probably made it 
a more sensitive measure of the expectancy effect. Appendix 22 details the 
distribution of athletes by endorsement of caffeinism symptoms. It appears 
that diuresis and insomnia are the most common symptoms reported after 
consuming caffeinated beverages. However, conclusions can not yet be 
reached regarding which of the symptoms a significant expectancy effect 
exists for. It is likely that some symptoms are more susceptible to an 
expectancy effect than others. 
Expectancies regarding caffeine's effects are very complicated and 
motivations for consuming caffeinated beverages are numerous. This may 
explain the discrepant findings between this and other research. For 
example, if a perceived negative such as a decrease in steadiness occurs on 
first exposure to caffeine, why do so many people continue to consume it? 
Perhaps the negative is outweighed by the concurrent effects which might be 
perceived as positive. This would be especially true is caffeine was initially 
sought for its expected and widely known alerting effect under conditions 
where a decrease in steadiness is not important, for example, in cycling but 
not in archery. The positive effects under those conditions combined with a 
quickly developing tolerance to the negatives might allow continued 
motivation for consumption. 
On the other hand, initial consumption under conditions demanding 
fine motor control might tend to discourage further consumption. Other 
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work consistent with this hypothesis suggests that tolerance does not 
develop to the alerting effects of caffeine, but does develop to many other 
caffeine effects including jittering (Goldstein et al., 1969). 
Lake (1988) reported that caffeine decreases boredom and relaxation and 
increases other ratings of subjective moods - anxiousness, tenseness, and 
nervousness. In addition to the alerting effects of caffeine, he suggests that 
real or expected mood changes experienced by regular caffeine users 
contribute to the motivation for consumption. Expected benefits for athletes 
might include improved performance on motor tasks, counteraction of 
fatigue-induced decrements, increased endurance, and enhancement of 
analgesic effects from over-the-counter pain relievers. 
The behavioural effects of caffeine -for example, increased alertness and 
decreased fatigue - have generally been assumed to be due entirely to this 
drug. However, studies have revealed that variables such as personality and 
the time of day the caffeine is consumed also influence the experience of 
caffeine-related symptoms. Apparently, knowledge of having consumed a 
large dose of caffeine creates an expectancy of experiencing certain effects and 
this expectancy exacerbates the actual effect of caffeine. Indeed, the results of 
Christensen et al. (1980) revealed a significant expectancy effect on five 
caffeine-type responses (alertness, headache, rapid heart beat, sleepy, and 
clear flow of thought). 
Because of the apparent complexities regarding cognitive functions, 
expectancies and the physiological effects of caffeine, overall conclusions 
about the effects of caffeine on physical performance are not possible at the 
present time. Research regarding the caffeine intakes and expectancies of 
athletes regarding this drug is in its infancy. Much needs to be done before 
firm conclusions can be drawn. Disparities in experimental methods have 
contributed to discrepant findings. 
Athletic Identity The AIMS was found to be a reliable, internally 
consistent instrument. The validity data obtained in this study provide 
support for the claim that AIMS assesses identification with the athlete role. 
This replicates the findings of Brewer et al. (1993) who validated AIMS in a 
university population. 
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A major hypothesis tested by this study was that athletes who identify 
strongly with the athlete role are more likely to engage in drug-taking 
behaviour than athletes who have only a weak athletic identity. 
Furthermore, athletes who compete at a national or international level are 
more likely to have a strong athletic identity than those participating at local 
community or regional level. 
This study showed a positive relationship between level of participation 
and athletic identity. Several potential risks for individuals with a strong 
athletic identity have been hypothesised (Brewer et al., 1993). For example, 
it is possible that a strong athletic identity may prompt individuals to engage 
in a sport or exercise activity to the extent that their physical health is 
jeopardised. In this study, the use of caffeine as a performance enhancing 
drug, was analysed as the sport activity that might jeopardise physical 
health. On the basis of athletic identity, there was a significant difference 
between those who use caffeine as an ergo genie agent and those who do not. 
In other words, athletes who 'use' caffeine as an ergogenic drug exhibit a 
stronger identification with the athlete role than non-users. The significant 
result can be taken to mean that caffeine use negates the potential 
health/fitness benefits of a strong athletic identity. 
High levels of commitment commonly accompany participation in 
sport. Many individuals ascribe a great deal of psychological significance to 
their sporting involvement and identify with the athlete role (Brewer et al., 
1993). These authors claimed that there may be both positive and negative 
consequences associated with strong athletic identity. On the one hand, 
committing oneself to the athlete role creates an opportunity to develop 
athletic skills, among other benefits. A strong, exclusive athletic identity 
may also have a positive effect on athletic performance. 
Evaluation of the Present Study 
The present study examined the role of expectancies and athletic identity 
on caffeine intake and caffeinism symptoms endorsed by subjects. However, 
it must be acknowledged that this study was not without limitations. The 
evaluation which follows addresses some of the general limitations of the 
study and specific methodological problems encountered. 
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Subject Selection The method of subject selection was less than perfect. 
This research was particularly constrained by practical aspects brought about 
by the Privacy Act. This meant that NSOs could not disclose athlete names 
to the researcher so subjects could not be contacted personally. Because 
athletes were contacted by their NSO or regional organisation, there is no 
guarantee that these respondents are a random sample or that they 
represent a cross-section of athletes. Furthermore, athletes could not be 
contacted personally to encourage the prompt return of questionnaires if 
they had not already been sent. This contributed to the smaller than 
optimum response. Time contraints meant that questionnaires could not be 
given directly to athletes by arranging visits to sports clubs around the 
Canterbury region or around New Zealand. 
Follow up Data from a sample of non-respondents should have been 
obtained to establish the reasons why so many subjects took up their right 
for non-participation, and to determine that those who did not respond 
were not systematically different from those who had. This potential bias 
based on non-response could reflect both external and internal invalidity 
based on experimental mortality (that is, selective, non-random loss of 
subjects from the 'random' sample) as well as a potential increase in 
sampling error. 
Expectancies Subjects were aware of the purpose of the study and were 
cued to possible effects of caffeine, which were described in the Perceived 
Consequences of Caffeine (EP-CAFF.l & EP-CAFF.2) questionnaires. With 
questionnaire surveys there is always a danger that respondents will answer 
questions in ways that reflect what they believe the experimenter wants to 
hear ("pleasing the experimenter"). 
With regard to the AIMS scale, although athletic identity may be 
primarily a trait-like construct, AIMS scores may be susceptible to social and 
situational influences. Perhaps athletic identity is stronger when one is in 
the presence of athletes or in a sport environment than when one is in the 
presence of non-athletes or in a non-sport environment. These 
assumptions have implications for the completion of the questionnaire. A 
question arise, "Did athletes want to appear as if they identified with the 
athlete role?" 
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The Scale If a similar study is to be conducted, the researcher would do 
well to refine the questionnaire. For example, although the EP.CAFF-2 scale 
showed internal consistency, there were a number of items that could be re-
worded. For example, the first four items opened with, "In my sport .... " but 
the other items were not worded like that. While this wording allows the 
researcher to draw conclusions regarding the athletes' beliefs for their own 
sport, it does not expose an overall belief. For example, an archer may have 
a great deal of knowledge about caffeine, and knows that it can increase fat 
utilisation in some sports, but not in archery. This athlete would be forced 
to answer "Na1' to the item that contains the "In my sport ... " prefix. 
However, if the item was re-worded, the response would be "Yes". 
A second criticism of the scale is that the questionnaire involved many 
forced choice items. For example, "Caffeine helps people stay alert. Yes or 
No?" Such items could be redefined on a Likert scale to avoid the problems 
forced-choice scales bring to multivariate analysis (Barrett, 1995). 
Converting any forced-choice items to Likert configuration would render 
the scales less limiting. Five to 7 points along a continuum should provide 
the necessary distinctions to answer the questions, without providing 
respondents the opportunity to make finer distinctions than they are 
prepared to make. 
Individual Questionnaire Items The questionnaire could have 
contained the question, "Do you deliberately refrain from consuming 
caffeinated beverages when competing/performing? Subjects were only 
asked if they did use caffeine as a performance enhancing drug. 
Furthermore, one respondent noted that they had intentionally used 
caffeine to enhance performance knowing the risk of disqualification but 
was not bothered by disqualification because "I have always been sure that I 
would not have been over the legal limit". These notes indicate that the 
questionnaire needs to be more comprehensive than its current form in 
order to widen its application. 
Age Future research could do better by defining the age limits of 
athletes. The age cut-off could have been defined at 40 years. This present 
research showed a significant difference between age and caffeine intake. It 
is also likely that those in different age brackets have different expectancies 
regarding caffeine. Indeed, Swift & Tiplady (1988) found that caffeine 
produces changes predominantly in the direction of improved performance 
on attention tasks and choice-reaction time tasks for both young (18-37) and 
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elderly (65 - 75) subjects. However the same study showed that the elderly 
were less able than the young to report the acute subjective effects of caffeine 
such as increased drowsiness and dizziness. This has implications for the 
questionnaire requesting subjects to report the symptoms they experienced 
after caffeine consumption. 
Habitual Caffeine Use and Tolerance to Symptoms Fisher et al. (1986) 
suggest that habitually high caffeine users acquire a tolerance to caffeine 
which reduces its effects during prolonged exercise and at rest. It seems that 
4 or more days of withdrawal from caffeine resensitises an individual to 
caffeine's physiological effects. Because of the great individual variation in 
response to caffeine, subjects may differentially report caffeinism symptoms 
according to sensitivity to the drug, caffeine tolerance, and ingestion of large 
amount of caffeine. For example, a caffeine-sensitive individual may be 
classified as experiencing 'caffeine intoxication' even after 1 cup of coffee. 
This may be a reason why caffeinism and caffeine intake were not related in 
this study. 
Individual Variation Caffeine makes some people more alert and 
energetic while it makes others feel nervous and shaky. This makes the 
ability to achieve statistical significance more difficult. The fact that this 
significance is not obtained, however, does not mean that for a number of 
subjects there is no ergogenic effect. Indeed, interpretation of nearly all 
reported studies is difficult since both positive and negative effects can be 
related to caffeine administration. 
Averaging Caffeine Intake and Caffeinism Symptoms Caffeine research 
relies heavily on scale items to measure intake. Most research tends to 
collapse caffeine intake by creating averages (eg. low, moderate, high). 
Moreover, previous research has reported caffeinism according to whether 
it is present or absent rather than on a scale of severity. This project 
followed the trend. While measurements based on averaging techniques 
are valuable, the occurrence of any one or more symptoms at a severe level 
should be given special mathematical consideration to avoid being diluted 
beyond recognition in the averaging process. 
The same criticsm applies to caffeine intake. For example, high intake 
was considered to be above 400mg per day in this study. This ignores the fact 
that a number of respondents consumed much more, in several cases, over 
800mg per day, and in one case, over 1000mg per day. That a significant 
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relationship was found between the 11 caffeine intake groups and the 
number of caffeinism signs (ranging from 1 to mt but not between the 3 
broader caffeine intake groups and caffeinism status (less than 5 signs versus 
5 or more signst is an excellent example of how the 'power' of a finding can 
be drastically reduced by regrouping data into a smaller (perhaps less 
meaningful) number of categories. 
On this note, data analyses would have been easier and more significant 
if real means could be calculated (for example, on the age and income 
items). That is, categorical and nominal variables can sometimes be difficult 
to work with. It also means a lot of manipulation is required when doing 
data analyses to recode the variables into more workable data. 
Response Patterns In this study, indications of caffeinism did not vary 
markedly from subject to subject (Appendix22). Some scale items seemed 
very relevant (for example, diuresis and insomnia) while others were of 
little value (for example, flushed face). 
Sampling Problem One of the reasons for the unsatisfactory results of 
this study may be the absence of an adequate consideration that it is specific. 
The lack of such an approach appears in the selection of the athletes. The 
study of athletes from various sports, combined in a heterogenous group, 
did not permit discovery of the personality characteristics which are 
different for the various sports. Also, this survey should be undertaken 
within a research design using comparison groups. That is, the athletes 
were not compared with non-athletes. Research on the athletic identity and 
personality of athletes needs simultaneous comparisons in two directions: 
athletes from separate sports with non-athletes and athletes of various 
sports among them. Socio-demographical factors have a great impact on 
personality and the specific sport an athlete choses (Geron et al., 1986) and 
should have been considered in this research. 
The personality profiles of athletes can not be considered as absolutes. 
They always appear relative to the population to which the athletes are 
compared. Participants in a sport differ from the non-athletic population by 
certain features and from the athletes of other sports, by other features. 
Therefore, when making the assumption that athletes scoring high on 
AIMS would be more likely to use caffeine as a PED; the sport engaged in 
and personality profile of the athletes, should have been taken into account. 
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Statistical Manipulation of the Scales Clearly, a more detailed data 
analysis would provide more comprehensive answers to the research 
questions. Additional suggested analyses include factor analyses of the 
individual items of the expectancy scales, the CAFFSX questionnaire, and 
the AIMS questionnaire. This would provide an indication of the extent to 
which each item contributes to the final scale score. 
Differences in Knowledge Subjects were asked whether the last drink 
they had was caffeinated or not. Most knew although a number were not 
sure. Respondent #236 did not know that Diet Coke contained caffeine, 
respondent # 333 did not know that water contained no caffeine, and 
respondent # 308 did not know that apple juice was non-caffeinated. A 
questionnaire more sensitive to these differences in subject knowledge 
regarding caffeine needs to be devised. 
Participant Criticism of the Scale Feedback in the form of handwritten 
margin notes on the questionnaire or separate letters from participants in 
the study raises three points for consideration. One participant (a target 
shooter) found the questionnaire limiting with regard that sport, in that it 
was not sufficiently detailed. Another (an archer) noted that caffeine 
exacerbated her arthritis symptoms. As a result she rarely consumed 
caffeinated beverages, and therefore believed she was in no position to 
complete the caffeinism symptoms questionnaire. The third issue relates to 
the variability of subject responses and shows that forced choice 
questionnaires, are by definition, limiting (as discussed above). I take the 
liberty of demonstrating this point with the notes of two respondents, the 
first an archer, and the second, a fencer: 
"In fairness I should point out that in my medical notes 
my doctor has branded me as a "caffeine addict". The 
quantities I indicated are averages, I can drink up to 16 
cups a day, and have for the past 13-14 years. I use it to 
wake up, sleep, relax and wind-up. I carry on this 
pattern while I'm participating in sport, not for 
enhancement, but for survival. I can get into the 
position that if I don't have it I get headaches and 
sometimes, although not often, three or four cups in 
quick succession will give me a headache. I'm finding 
recently that I'm getting the shakes if I haven't had 
coffee so I drink a glass of coke for quick relief." (anon.) 
" ... caffeine is very bad for my performance in fencing. If 
anything I require relaxing before competition." (anon.) 
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Suggestions for Future Research 
It is an additional methodological criticism of the present study that 
leads to suggestions for future research: the methodology used in this study 
'wastes' data. That is, there are many data generated from this project that 
were not used. A number of research ideas, which can be answered by the 
analysis of this data and the generation of further data, merit exploration. 
The ideas fall into four categories - issues involving the personality of 
athletes, the use of other drugs, sport specific expectancies, and motives and 
rationalisations for caffeine use in sport. 
Personality of Athletes This study made the assumption that athletes 
with a strong athletic identity would be more likely (than athletes who do 
not identify strongly with the athlete role) to engage in a sport activity to the 
extent that their physical health is jeopardised. The exercise activity in 
question was caffeine abuse. However, there are two flaws in this 
assumption. 
First, caffeine consumption can not be regarded as a dangerous 
behaviour relative to other behaviours an athlete might engage in, such as 
competing with a serious injury or the use of anabolic steroids. Indeed, 
caffeine's ubiquity places it in a position that it is rarely classified as a drug by 
the non-scientific community. Therefore, illicit and arguably more 
dangerous drugs, such as anabolic steroids may be more appropriate when 
comparing behaviour with AIMS. 
Second, the personality profile of an athlete may have a bearing on the 
propensity to use performance-enhancing drugs. Research suggests that the 
personality profiles of athletes in various sports are not homogeneous 
(Geron et al., 1986). Although some consistent personality characteristics 
have been found for athletes, there are also some differences. For example, 
sprinters have been found to be more anxious, emotionally disturbed and 
tense than a matched sample and athletes of other sports. These personality 
characteristics, which are generally accepted as unfavourable, may be 
favourable for participation in this sport, thus justifying that high level 
athletes possess them. It is worth investigating whether athletes of different 
sports exert personality characteristics indicative of drug taking behaviours. 
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Another application of caffeine research would be to examine the 
relationship between caffeine consumption and the incidence of caffeinism 
in athletes using the State-Trait Anxiety Inventory (STAI) and the Beck 
Depression Scale (BDE). This would provide a further indication of the 
relationship between personality (specifically trait anxiety and depression) 
and use of caffeine as a performance enhancing drug. It may be that the 
STAI and the BDE are more reliable indicators of problem caffeine use than 
the CAFFSX scale developed for this study. 
Utility of the AIMS A great deal of attention has been focused on the 
relationship between personality and sports participation. Definitive 
conclusions regarding the presence of an 'athletic personality' and the 
consequences of various levels of athletic participation have been limited by 
methodological shortcomings and equivocal findings (Hauck and 
Blumenthal, 1992). An interesting comparison could be made of athletes 
scores on the Minnesota Multiphasic Personality Inventory and AIMS. 
Another obvious use for the AIMS is to investigate the relationship of 
athletic identity to drug taking by athletes. It seems that this scale is 
sensitive to caffeine, despite its ubiquitous nature. The association of AIMS 
to the use of other drugs could also be tested. Should a strong, exclusive 
athletic identity be found in subsequent research to function as a 
vulnerability factor for drug-taking, the AIMS could be used as a means of 
identifying individuals who are at risk. Preventive interventions could 
then be implemented to help athletes at risk avoid drugs. Perhaps 
interventions involving valuing competence in non-sport activities would 
prevent athletes from placing too much importance on sporting success and 
from resorting to drug-taking to achieve that success. 
In this study, males and females did not score differently on the AIMS. 
Brewer et al. (1993) revealed a significant difference on the basis of gender on 
AIMS scores, suggesting a greater emphasis in United States' society on sport 
for males than for females. That the interaction between sex and level of 
athletic involvement was no statistically significant in this study does not 
necessarily mean that an equal emphasis is placed on sport for both males 
and females in New Zealand. Rather it indicates that the two studies tested 
different subject pools (college students and athletes). If this study was to be 
replicated and AIMS tested using a matched sample of New Zealand 
university students, males may well score higher than female on AIMS. 
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Rationalisations for Caffeine Use and Sport Participation Motives It 
would be valuable to obtain athlete's attitudes and rationalisations for 
caffeine use as a PED: why do athletes use caffeine, where did they learn 
about the effects of caffeine, and what values do they associate with this 
form of drug use? For example, if athletes are using caffeine as a means of 
reducing body fat, are they also exhibiting any of the symptoms of anorexia 
or bulimia nervosa? In this study assumptions were made about athletes' 
motivations for caffeine use based on their sport. It was assumed that the 
motives for using caffeine use during competition would largely be related 
to decreased fatigue and increased time to exhaustion, to increased alertness 
and vigilance, and to weight reduction. However, athletes may well use 
caffeine for effects not related to performance enhancement. Such reasons 
are: the apparent reduction of negative psychological reaction to challenge; 
relaxation; to buffer withdrawal symptoms experienced after a period of 
abstinence; or, as a normal part of their socialising. 
It is imperative to recognise athletes' reasons for taking caffeine so that 
strategies can be devised to reduce, if not eliminate, the problem (if it can be 
considered a problem). This is especially so if athletes are displaying 
symptoms of caffeinism. Younger athletes are particularly susceptible to the 
health hazards of caffeine. Research into understanding the causes of 
caffeine use among athletes remains scant, perhaps because it is a 
recreational drug of a ubiquitous nature. However, it is also a potential 
performance enhancer and a potential health hazard. In order to educate we 
need know whether caffeine is used for the need to be competitive, to 
increase strength, to cope with stress, to reduce pain, to relax, to control 
weight, or to overcome boredom. 
Another useful application of this research would be to study the extent 
to which athletes sport participation motives (Ryckman & Hamet 1993) 
impact on their AIMS and their use of caffeine. For example, future 
research could examine the importance of intrinsic versus extrinsic reasons 
for the participation in sports, and their relationship to athletes' AIMS and 
caffeine intakes. Participation motives that could be studied include: 
improvement of skills, enjoyment of competition, maintenance of fitness, 
wish to represent New Zealand, recognition, social contact. While this 
information was elicited from subjects in the present study, no comparisons 
were made. However, interesting and valuable information could be 
provided about the particular motives athletes scoring higher on AIMS 
consider important reasons for participation in sport. 
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Other Drugs Two considerations are important here. First, because of 
the ubiquitous nature of caffeine, this drug is not an easy one to study in 
relation to sport. It is apparent that many athletes, as yet, do not have the 
relevant information available to them regarding caffeine and its potential 
as an ergogenic agent. Therefore, other ergogenic drugs such as 
amphetamines or steroids may have been easier to study. Furthermore, it 
may be interesting to examine whether athletes using caffeine as a 
performance enhancing drug are also using illicit drugs on the sports field. 
Future research could also examine subjects use of other social drugs 
such as nicotine and alcohot their interactions with caffeine, and athletes 
perceptions thereof. For example, Kerv et al. (1991) showed that motor 
function was facilitated by nicotine and caffeine and that the debilitating 
effects of alcohol were frequently antagonised by either drug. Others have 
found that with the exception of reaction time tests, caffeine does not 
antagonise ethanol-induce performance decrements (Millis, 1987). 
Combinations of these social drugs need to be considered. However one 
would assume that athletes would be non-smokers and abstainers from 
alcohol or at the very least, only light drinkers and smokers. 
Expectancies and Sport Future research could do well to assess which 
sport-specific expectancies athletes of various sports maintain. For example, 
does an archer or shooter know more about caffeine's effects on anxiety and 
tremor than on the sparing of muscle glycogen? Would this be reversed for 
cyclists and triathletes? The data was available to answer such questions but 
the additional analyses required were not undertaken at the time of writing. 
Discriminant analyses could be conducted to determine if there are any 
items on the EP.CAFF-2 scale which stand out for particular sports. 
Some researchers (Butts & Crowell, 1985; Flinn et al., 1990) suggest that 
only well-trained athletes can benefit from caffeine. However, Casal and 
Leon (1982) have suggested that caffeine only has a positive effect on non-
elite athletes since they do not have the increased lipolytic enzyme activity, 
mitochondrial density or size that endurance activities brings about. Do 
these athletes perceive caffeine's effects differently? Similarly athletes with 
high amounts of caffeine in their normal diet have been found to build up a 
tolerance to the substance (Fisher et al., 1986) which prevents caffeine from 
having its purported ergogenic effect. Does this influence performance 
enhancing expectancies? Obviously, there is a great deal of scope remaining 
for the investigation of caffeine in sport. 
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Educating Our Athletes 
One of the functions of the NZSDA is to "foster the development of 
educational programmes and materials which will reduce the unethical use 
of drugs and doping methods in sport" (Hatherton, 1991, pl3). The same 
report notes that the "correct use of the sport sciences should be promoted 
and developed as an alternative to misuse of PEDs" (p15). However, 
estimates of the cost of an education programme involving specific drugs-
in-sport educational material and methods stand at around $250 000 per 
annum. When this amount of money is concerned, it is not surprising that 
drug education efforts are focused on the drugs with more 'serious' effects 
than caffeine, such as the anabolic steroids, narcotics, and amphetamines. 
Drug education is an important facet of school programmes today. The 
Foundation for Alcohol an Drug Education (FADE) has been set up to 
highlight the risks of alcohol and drug abuse to school children. Popular 
athletes are spokespeople for the foundation. Caffeine is not on the 
programme and because of the ubiquitous nature of caffeine in society the 
"Scared Straight" type of education does not seem relevant. 
The question arises, should our athletes and our youth be educated 
about the potential effects of caffeine. Given the limited budget and the 
necessity for education about other drugs, caffeine education is not a 
priority. Furthermore, caffeine is only banned in high doses so perhaps 
athletes could be educated as to how caffeine can be used safely and legally to 
enhance their sporting performance. Thus caffeine could be used to its full 
ergogenic effects as a nutritive aid whilst the athlete's health is not 
compromised, and nor is she or he cheating. 
Despite caffeine being a relatively safe drug, there is a place for education 
about its effects. There can be little doubt that many adolescent athletes are 
taking caffeine. As a result, they are also experiencing the toxic effects of 
this drug - tremor, hyperactivity and diuresis. Although cola beans 
themselves contain little caffeine, the drug is intentionally added by soft 
drink manufacturers, making cola drinks the major source of caffeine for 
adolescents even if they are unaware they are consuming a drug. 
Athletes need to be alerted to the fact that caffeine is a drug and that 
caffeine-containing beverages do have the potential to influence mood. 
Furthermore, the psychoactivity of caffeinated beverages creates some 
possibility of dependence. 
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Educational efforts should also include 
information about which food and drink products contain caffeine and the 
respective amounts of caffeine they contain. Accurate and current 
information about the potential health effects of caffeine consumption 
should also be provided to athletes. 
The First Permanent World Conference on Doping in Sport (1988; cited 
in Hatherton, 1991) considers three elements to anti-doping education. The 
first involves educating athletes and significant others about the ethical 
basis of sport, and the notion that doping is 'cheating'. The second involves 
educating athletes of the dangers of drugs from a health standpoint. The 
third involves providing information about national and international 
anti-doping rules and the lists of classes of banned substances. 
Regarding the first consideration, this element of educ9tion does not 
have to be made specific to the different classes of drugs. Therefore, this 
element of education is already covered for caffeine. Concerning the second 
point, that athletes need to be educated about the negative health 
consequences of doping. Research suggests that caffeine can be a relatively 
safe drug, so it might not be necessary to educate athletes on this level 
(except if they are abusing very large quantities). On the third point, New 
Zealand's top athletes are provided with the information they need1 even 
for caffeine. They are issued with a plastic wallet-sized quick reference card. 
I 
One side (Figure 8) gives a list of doping classes and methods banned, while 
the reverse side (not shown) provides examples of permitted and banned 
substances for various symptoms (for example, asthma, cough, headache). 
Such information is not given automatically to lower grade athletes, but it is 
available upon request. Whether the current education philosophy for 
caffeine is adequate or not, remains to be seen. 
/
~---D-O_P_I_N_G_C_O_N_T_R_O_L_BN_S_P_O_R~T-~~ 
. Valid until Juno 1994 
INTERNATIONAL OLYMPIC COMMITTEE 
DOPING CLASSES AND METHODS BANNED 
STIMULANTS amphetamine, cocaine, ephedrine, and related compcunds. 
•carte!ne reslflcted to 12 microgm/ml. 
NARCOTIC ANALGESICS morphine, pethidine, and related compounds, 
ANABOLIC AGENTS 
Androgenic Anabolic Steroids nandrolone, stanozolol, testosterone, and related compOUnds. 
Other AnabolJc Agents clenbuterol (Beta.2 agonlsts.) 
DIURETICS frusemfde, hydrochlorothlazlde, splronolactor.e. trlamterlne and 
related compounds. 
PEPTIDE HORMONES AND ANALOGUES Growth hormone, HCG, ACTH, El'O, 
. BLOOD DOPING, PHARMACOLOGICAL, CHEMICAL AND PHYSICAL MANIPULATION eg.masklng 
ALCOHOL, MARIJUANA, BETA BLOCKERS Not banned but may be resl!lcted by lnolvldual 
sports bodies. 
LOCAL ANAESTHETJCS, CORTICOSTEROIDS af!owed for approved treatments cerUtied bot Doctor. 
~ _.,,. For More lnformation ® 
~•, c _m..:,,,::n,_u;,rs Phone N.Z.S.D.A. NZ Federation ,....'1J Sr-illlTSDRUGAGEHCY (09) 521-5706 ofSportsMe<ficine 
i(u P.O. Box 18-339 Auckland 
Figure 8 - NZSDA Card given to Elite Athletes. This card 
provides summary information of doping controls in sport 
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Implications for Athletes 
Athletes have used caffeine as an ergogenic aid for many years. The 
exact mechanism of that aid is unclear because of caffeine's broad 
performance-altering metabolic and physiological effects. The following 
discussion is intended to provide athletes, their coaches and influential 
others, with valuable, objective information regarding caffeine's place in 
sport. 
Doping and the International Olympic Committee The IOC has banned 
'high levels' of caffeine1 but monitoring its use and abuse is difficult. 
Caffeine is a legal drug and athletes are free to experiment with its use. 
However, enhanced performance, as evidenced by continuously improved 
records since the turn of the century, correlates much more with improved 
training methods, better materials and equipment, improved nutrition, and 
improved psychological techniques than with the use of ergogenic drugs. 
The IOC considers caffeine to be a drug and does not sanction its use by 
athletes. The pertinent research has shown some positive implications for 
caffeine's performance enhancing effects, but the use of caffeine by athletes 
as an ergogenic aid cannot be condoned. 
Caffeine fits into three categories. It can be used to diminish the 
perception of pain and therefore reduce suffering from injury as an end in 
itself (therapeutic use of the drug) rather than as a means to an end 
(improving performance or altering perceptions). Thus the explanations 
and categories for drug use may not always be mutually exclusive. Rather, 
they are interactive. Since caffeine affects most systems of the body, athletes 
who wish to experiment with it should do so before competing in any 
world-class or critical event. 
Sport Performance Variables Caffeine affects muscle function, and it 
has been shown to enhance performance in endurance events and in 
activities requiring increased alertness1 decreased reaction time, and lowered 
anxiety levels, such as archery and shooting. Studies have shown that 
caffeine has no ergogenic effect on large-muscle, short-term intense exercise 
requiring strength and power (Van Handel, 1983). 
The substrates that are used as fuel for endurance activities are mainly 
free fatty acids and muscle glycogen. The longer muscle glycogen is spared, 
the greater the delay in the onset of exhaustion (Ivy et al., 1979). Caffeine's 
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ability to mobilise plasma free fatty acids is theorised to have a glycogen-
sparing action during exercise (Slavin & Joensen, 1985). According to the 
American Dietetic Association, the theorised glycogen-sparing action of 
caffeine may offset fatigue, but its negative side effects may outweigh the 
possible benefits (Smith, 1987). 
Contradictory data abound with respect to caffeine's effect on other 
measures of performance that are important in athletic competition. Poorly 
substantiated reports of less drowsiness, increased vigilance, reduced fatigue, 
and an increased capacity for sustained concentration have all contributed to 
the widespread use of caffeine (Powers & Dodd, 1985). Subjective feelings of 
increased alertness and nervousness are evident when no objective 
improvement in alertness, psychomotor performance following caffeine 
ingestion exist (Goldstein et al., 1965). 
The Magic Dose The positive effects of caffeine appear to be dose-
related. However, the actual amount of caffeine needed to enhance 
performance is still not known and individual variability will affect the 
amount. The literature suggests that an intake of 4 to 5 mg per kilogram of 
body weight (2 cups of coffee [300mg] for a 70kg person) results in a 
significant plasma caffeine level within 15 minutes (Essig et al., 1980). 
Furthermore, the positive effects of caffeine also to be affected by the 
amount of caffeine normally consumed by the subject. 
Masking of Fatigue Caffeine can produce a physiological masking of 
fatigue (Lombardo, 1986) which causes athletes to be unaware of changes to 
various physiological parameters, even when they reach dangerous levels. 
That is, instead of preventing fatigue (although it may delay it through 
glycogen sparing) caffeine masks the effects of fatigue and interferes with the 
body's fatigue-alarm system, which could be disastrous under extreme 
environmental conditions (Dyment, 1987). That caffeine can allow athletes 
to continue to exercise at high levels of effort for a longer period and endure 
a higher level of anaerobic metabolism poses a threat. In short-distance 
events this may not be dangerous but in events lasting for more than an 
hour, the failure to be aware of 'danger signals' and to react to them could 
be an threat to life. 
Anxiety Shanahan & Hughes (1986) have found that caffeine can 
potentiate performance-induced anxiety. This has implications in the sports 
arena. Athletes will have to weigh up this affect of caffeine and the reported 
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benefits. If caffeine use is viewed as a means to ameliorate the emotional 
effects of competitive stress, caffeine seems an unlikely drug to use for that 
purpose. This being the case, caffeine consumption should be decreased 
during sport, especially if an athlete is particularly vulnerable to stress. 
A high caffeine intake is has also been associated with symptoms of 
anxiety neurosis. However, Raitliff-Crain et al. (1989) found that caffeine 
can reduce negative mood and discomfort attributed to challenge while 
increasing indices of sympathetic arousal. The stimulating properties of 
coffee, coupled with its apparent buffeting of perceived stress places it in a 
paradoxical position. 
Habitual Caffeine Use Although positive effects of caffeine 
administration may occur for parameters associated with general perception 
of well-being or reaction time, it is perhaps equally likely that negative 
effects may occur depending upon the current caffeine status of the subject. 
It may also be true that administration of caffeine after a period of forced 
abstinence may be of benefit to an athlete considered a regular user. In other 
words, athletes who abstain from caffeine for several days and then resume 
intake apparently receive better results than chronic users. 
Definitive tests have shown that habitual caffeine users establish a 
tolerance to caffeine that is evident both at rest and during exercise (Fisher et 
al., 1986). That is, regular consumption diminishes its stimulant effects so 
that increasing dosages are needed to get that effect. However, the 
occasional user of caffeine will probably notice increased effects from smaller 
doses of the drug. When tolerance to coffee does occur, resensitisation to 
caffeine's physiological effects can occur by increasing the dose, or by 
complete abstinence over as little as four days. 
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Bullet Point Summary of Caffeine's Effects 
• Physical dependence on caffeine can develop and withdrawal symptoms 
may occur upon cessation of caffeine (Holtzman, 1990). 
• Athletes who habitually consume caffeine need to abstain from caffeine 
for 4 days in order to magnify its effects. 
• High intakes may result in fluid loss, polyuria, increased heart rate, and 
an increased anxiety level that may outweigh any positive effects on fuel 
utilisation or alertness. 
• Well-trained endurance athletes already use fatty acids effectively and 
thus spare their glycogen. The benefits of caffeine may therefore be small. 
• Carbohydrate loading negates the ergogenic effect of caffeine by 
dampening its fat mobilising effect. 
• Caffeine-induced improvements in aerobic exercise (incremental or 
steady state) are related to increases in free fatty acid utilisation, thereby 
sparing carbohydrate and delaying the onset of fatigue. 
• Caffeine needs to be taken 3 to 4 hours before aerobic exercise in order for 
FFA levels to reach their peak to take advantage of the glycogen-sparing 
effects. 
• Anaerobic exercise tasks should commence 1 hour after caffeine ingestion 
when plasma levels are highest. 
• Caffeine-induced increases in anaerobic exercise may be more likely due 
to neurologic stimulation, or a reduction in the sensation of fatigue, but 
not to use of fuel. 
• Due to alterations in fluid and electrolyte balance, caffeine ingestion has 
potential deleterious effects on work tolerance and thermal stress. 
• Impaired memory, pronounced anxiety, and sensory disturbances 
(hallucinations) are some of the results of ingesting massive doses of 
caffeine by humans under prolonged competitive stress (Stillner, 1978). 
• The benefits sought from caffeine's ergogenic properties (eg. delay in the 
onset of fatigue, weight control) must be weighed against any potential 
cost (eg. decreased accuracy, impaired muscular coordination, diuresis). 
• Individuals engaged in sensitive and hand steadiness-dependent sports 
could benefit form the knowledge that a reduction of caffeine intake may 
avoid tremor and loss of fine motor coordination. 
• Athletes should consider previous caffeine tolerance and their body size 
before estimating appropriate caffeine dosage. It would be prudent to keep 
caffeine consumption to within 2 to 3 cups of coffee (Smg.kg-1) prior to 
sports activity (Slavin & Joensen, 1985). 
• The use of caffeine in sport should be viewed with caution. It can cause 
adverse effects as mentioned previously. In addition, there may be 
individuals who are particularly sensitive to caffeine, resulting in over-
stimulation of body systems and thus causing the opposite effect 1n 
performance from that desired. 
• Watson (1988) gives practical solutions to those wishing to reduce or 
eliminate their caffeine consumption. 
84 
Negative Consequences of Caffeine Use for Athletes 
Possible side effects that could limit sports performance include insomnia, 
withdrawal headache, diarrhoea, anxiety, irritability, and increased urine 
production. Individual response to caffeine differs and depends on past use, 
body composition, and dosage. 
From an athletic perspective, high intakes of caffeine may result in fluid 
loss, polyuria, nausea, increased heart rate and anxiety. These effects may 
outweigh the positive effects of fuel mobilisation and alertness. Even 
modest doses cause side effects of tremor, insomnia hyperactivity and a 
diuretic effect with possible diarrhoea (Passmore, 1987). However, the 
health consequences of acute and chronic caffeine intake appear to be 
minimal compared with other stimulants. Moreover, few restrictions are 
placed on the use of caffeine. These considerations suggest that caffeine can 
indeed be a convenient, relatively safe and useful drug for athletes. A 
number of health issues of concern to athletes do warrant discussion. These 
are athletic amenorrhoea, eating disorders, diuretic tendencies, thermo-
regulation, food iron absorption, and toxicity of caffeine. 
Athletic Amenorrhoea This is a major problem affecting women 
participating in competitive sports (Hellemans, 1990). Concern is related to 
the low bone density levels of many of these women which predisposes 
them to osteoporotic fractures. Diet is implicated in the aetiology of athletic 
amenorrhoea (Myerson et al., 199lt including an association with a low 
calcium diet. Ingesting excessive caffeine increases calcium excretion about 
50% (Massey & Hollingbery, 1988\ meaning even less calcium is available 
for bone health (Shah & Belonje, 1988). High caffeine consumption has 
been proposed as a risk factor for osteoporotic fracture, but the evidence 
associating high caffeine intake with low bone density is inconsistent 
(Cooper et al., 1992). 
Eating Disorders These are also prevalent among female athletes. 
Male athletes may also suffer from eating disorders, especially those who 
have to 'make weight'. Caffeine abuse has been linked to bulimia and 
anorexia nervosa (Fahy & Treasure, 1991; Pruitt et al., 1991). Patients use 
caffeine for its appetite suppressant, diuretic, and stimulant effects, and are 
likely to suffer from caffeine intoxication. Indeed, caffeine has been used in 
weight loss preparations and regimens. This is a result of its negligible 
energy values and its thermogenic properties (Astrup et al., 1990; Curatolo & 
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Robertson, 1983; Dulloo et al., 1989). Caffeine increases the metabolic rate 
during the first several hours after ingestion by 14% in non-users and 
occasional users, but not in habitual users (Poehlman et al., 1988). 
Endurance-trained athletes also have a blunted response to the thermogenic 
actions of caffeine (Poehlman et al., 1988). Wilcox (1982) demonstrated that 
fat loss by rats doing aerobic exercise can be increased when caffeine is 
ingested prior to training sessions. Body weight, fat-pad weight and fat-cell 
size were all significantly lower in the caffeine trials. Some athletes take 
caffeine for its supposed weight loss benefits. One mechanism for this effect 
is the short-term reduction of calorie intake following caffeine 
consumption, but this effect seems to be restricted to males (Tremblay et al., 
1988). 
For men using caffeine, care should be taken to ensure their dietary 
needs are met, especially their protein intake. The mean caloric reduction 
following caffeine ingestion was 21.7% less than under placebo conditions 
(Tremblay et al., 1988). This reduction could have deleterious effects on 
athletic performance, especially if the deficit continues over a period of time, 
and lean body mass is compromised. Energy expenditure increases with 
caffeine in men but not women, that is, a greater disturbance of homeostasis 
occurs in men than women, when factors affecting the sympathetic nervous 
system, such as drugs and exercise are studied. 
Diuretic Properties and Urinary Mineral Excretion Caffeine has long 
been touted as a diuretic (Bellet et al., 1969), increasing an athlete's risk for 
dehydration and heat-related illness when performing in hot 
environments. Hellemens (1991) and Clement (1991) discuss the 
importance of adequate hydration for both athletic performance and 
regulation of body temperature. Some authors report that caffeine does not 
cause a significant diuretic effect (Birkett et al., 1990; Massey & Hollingbery, 
1988). However, Passmore et al. (1987) found that caffeine ingestion 
increases urine volume as well as sodium, chloride and potassium 
excretion. A balance of electrolytes is particularly important during training 
and competition. In comparison to other diuretics, caffeine is one of 
relatively low potency, and tolerance to this effect does develop (Curatolo & 
Robertson, 1983). Caffeine also acts on the smooth muscle (Graham, 1978) of 
the gastrointestinal tract, suppressing motility in the stomach and small 
intestine, but relaxing the muscle of the large intestine. An endurance 
athlete should think twice about ingesting caffeine before an event, during 
which even a minor case of diarrhoea could be a major inconvenience! 
86 
Body Fluid Balance and Thermo-regulation Normally, exercise- and/ or 
thermally-induced sweating reduces urine output, thus conserving both 
water and electrolytes. A large caffeine-induced diuresis under these 
conditions may compromise the circulatory and sweat response to internal 
heat production. However, the effect of caffeine on body temperature is 
difficult to interpret. It may be a consequence of increased motility, a 
calorigenic effect, or a direct central effect on temperature regulation. 
Waldeck (1973) found that caffeine partially counteracted the hypothermia 
caused by reserpine in mice. Falk et al. (1989) found that caffeine (2.Smg.kg-1) 
did not produce any significant adverse effects on body fluid balance or on 
the thermoregulatory and metabolic response in subjects exercising in 
thermoneutral conditions. That other authors have noted thermogenic and 
diuretic properties of caffeine, led Falk et al. (1989) to speculate that exercise 
under more stressful environmental conditions, or after higher doses of 
caffeine may hinder thermoregulation. 
Food Iron Absorption Tea is a well known inhibitor of food iron 
absorption but studies have also shown that coffee significantly inhibits food 
iron absorption by as much as 83%. The inhibition of iron absorption is 
concentration-dependent (Morck et al., 1983). This has profound 
implications for endurance athletes who require sufficient iron for efficient 
oxygen transport around the body to feed working muscles. The time of 
caffeine ingestion has an important effect on iron absorption. When coffee 
and iron-rich food are taken together, or when coffee is ingested one hour 
after food, the degree of iron inhibition is similar, but there is no inhibition 
when coffee is taken one hour before food. 
Toxicity Caffeine is not free of toxic effects. However, some effects are 
trivial in nature compared to the benefits derived from its use. In the 
modest doses usually used by athletes, it is unlikely to produce side effects 
more significant than some tremor and hyperactivity (phenomena not 
unknown to heavy coffee drinkers). However, the central excitatory effects 
of caffeine may cause an athlete to become oblivious to fatigue symptoms, 
even when they reach dangerously high levels. Fatigue is the expected 
consequence of sports competition and a part of the body's built-in biological 
warning system. Falls (1968) states: 
Drugs make men (sic) ignore danger signs which are a threat 
to man's (sic) physiological and psychological reserves. 
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As the consumption of caffeine increases, the effects on the body become 
more noticeable and severe. For a healthy adult, about two 150ml cups of 
brewed coffee (85 to 250mg) would decrease drowsiness, fatigue, and allow 
an easier flow of thought. For most people, this is the desired effect. 
However, a review of caffeine abuse research (Hughes et al., 1992) revealed 
that abstinence from caffeine induces a withdrawal syndrome of headache, 
fatigue, and drowsiness, that begins within 12 to 24 hours and lasts about 
one week. The syndrome can be severe and appears to be one reason for 
continued use of caffeine. 
Caffeine also has psychotropic and addictive properties. It can produce a 
set of behavioural and physiological symptoms in people who consume 
high doses (500 to 1000mg daily), wh are caffeine-sensitive, and who are not 
accustomed to using caffeine. This is known as "caffeinism" or "caffeine 
intoxication" (DSMIII-R,1987), the symptoms of which are similar to anxiety 
neurosis (Shanahan & Hughes, 1986; Davis, 1990), and include restlessness, 
nervousness, excitement, insomnia, flushed face, diuresis, gastrointestinal 
disturbance, muscle twitching, rambling flow of thought and speech, 
tachycardia or cardiac arrhythmia, periods of inexhaustibility, and 
psychomotor agitation (Stavric, 1988). In sensitive individuals, caffeine has 
even caused convulsions and vomiting. 
At doses greater than lg per day, muscle twitching, rambling flow of 
thought and speech, cardiac arrhythmias, periods of inexhaustibility, and 
psychomotor agitation may also occur. Impaired memory, pronounced 
anxiety, and sensory disturbances including hallucinations are some of the 
results of ingesting massive doses of caffeine by humans under prolonged 
competitive stress (Stillner, 1978). The acute human fatal dose appears to be 
greater than 10g (or 170mg per kg body weight; Graham, 1978). Death may 
result from seizures and respiratory failure (DSMIII-R, 1987). The amount of 
coffee required to provide 5 to 10g caffeine has been reported variously as 
"40 cups of strong coffee over a short time" (Work, 1991) and about "75 cups 
of coffee ... at one time" (Curatolo & Robertson, 1983). Other authors report a 
lower lethal dose (Watson, 1988), and even a small amount injected directly 
into the blood stream, can be fatal (Fisher & Jensen, 1990). However, deaths 
related to caffeine overdose are uncommon (Leonard et al., 1987), and only a 
few cases have been reported in the literature (Stavric, 1988). 
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CONCLUSION 
The literature describing caffeine's effects on sport performance is vast 
and equivocal. Caffeine research faces almost every imaginable 
methodological difficulty including conflicting results in sound studies. In 
light of equivocal findings, the benefit of caffeine as an ergogenic aid is 
questionable and athletes should therefore be discouraged from using it. If 
a naive user ingests it there is no way of predicting what the results would 
be. Indeed, caffeine could harm a persons performance by causing irritability 
and nervousness. To encourage the use of caffeine to improve performance 
could be seen as an endorsement of the use of drugs, which would be both 
inappropriate and unethical. On the other hand caffeine use could be 
endorsed if it were seen as purely a nutritional aid, not unlike the practice of 
carbohydrate loading. Overall, it appears that moderate use of caffeine will 
not cause problems for most people. But athletes who are susceptible to its 
effects, such as those who respond with arrhythmias should avoid caffeine. 
This project attempted to assess the effect of caffeine consumption on 
expectations of caffeine enhanced performance and caffeinism symptoms 
among New Zealand athletes. It was hypothesised that higher caffeine users 
would have greater performance-enhancement expectancies and would 
exhibit a greater number of caffeinism signs. This assumption was 
supported by the general body of literature describing the physiological 
effects of increased levels of caffeine consumption as well as two specific 
studies (Bradley & Petree, 1990; Page, 1987) which related caffeine 
consumption to expectancies of performance benefits. It was also 
hypothesized that athletes who had a strong athletic identity would be more 
likely to have used caffeine as an ergogenic aid. This assumption was made 
on the basis of a comment regarding the AIMS (Brewer et al., 1993). These 
authors suggested that a strong athletic identity may prompt individuals to 
engage in a sport behaviour that could jeopardize their physical health - this 
project tested this assumption using caffeine abuse as the behaviour in 
question. 
This study found no relationship between normal caffeine intake and 
level of caffeinism. However a relationship was found regarding caffeine 
expectancies and the extent to which an athlete exhibits the symptoms of 
caffeinism. It was also found that subjects who have sport-performance 
expectancies are more likely to use caffeine as a performance enhancing 
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drug. Furthermore, athletes who took caffeine as an ergogenic drug were 
more likely to identify strongly with the athlete role. 
Given a study with minimal methodological shortcomings, athletes' 
expectations of enhancing their performance through caffeine consumption 
may offer some promise as a predictor of the extent of caffeine consumption 
by athletes and their concomitant risk of caffeinism. This study contains 
some valuable information and could be treated as a pilot study for anyone 
wishing to continue with the research. Naturally the questionnaire must be 
refined, along with the method of subject selection and follow-up. Several 
other research suggestions are made which may clarify the links between 
caffeine and sport. 
There are only a few documented cases of positive drug tests returned 
for caffeine in international competition. But this may be the tip of the 
iceberg. The banned level of caffeine is set so high by the IOC that caffeine is 
not recognised as a drug of 'abuse' at lower levels, despite the fact that 
athletes may be showing signs of caffeinism, a condition of clinical 
significance. 
Additional scientific research to ascertain the extent of caffeine use in 
contemporary sport is needed. It is hoped that the results of this study will 
galvanise researchers to go beyond the limitations of the all-too-often 
reported anecdotal evidence. Instead, assessments of the relationships 
between the athlete's knowledge, attitudes, and drug-taking behaviours 
need to be undertaken in a systematic and scientific fashion. Only then can 
coaches, sport administrators, sport psychology consultants, and athletes 
work jointly to use caffeine safely and to inhibit the unethical and 
unhealthy use of the drug amongst the individuals who have traditionally 
been the healthiest models in our society, sports competitors. Nothing less 
than the integrity of the game is at stake. I leave the reader with a thought-
provoking quote: 
'In tlie oCtf days, at competitions, peop{e wou{d c{uster 
round tlie cliampions asking them about their e?(f,rcise 
routines. 9{pw they just as{( ''What drugs are you on?' -
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Beverages consumed at least once a week 
Fizzy Decaf. Coffee Milo Coffee Tea 
Substit. Cocoa 
TOTAL (Age 15+) 42%* 19% 6% 32% 87% 93% 
Males 1. 15-18 82 15 5 41 79 85 
2. 19-24 68 19 2 37 92 81 
3. 25--44 55 17 5 35 91 93 
4. 45-64 29 16 6 24 90 96 
5. 65+ 17 21 5 24 87 99 
6.ALL 50 17 5 32 89 93 
Females 1. 15-18 63 18 5 43 75 76 
2. 19-24 57 17 5 40 81 87 
3. 25-44 34 18 8 35 86 94 
4. 45-64 23 19 8 24 88 96 
5. 65+ 16 27 7 23 85 98 
6.ALL 35 20 7 32 85 93 
* Percentage of sample; Male respondents=2083, Female respondents=2603 
Appendix 2 
Frequency of Consumption of Beverages 
Fizzy Decaf. Coffee Milo Coffee Tea 
Substit. Cocoa 
TOTAL (Age 15+) 3* 12 9 6 19 23 
Males 1. 15-18 3 7 9 4 14 13 
2. 19-24 5 13 # 8 18 18 
3. 25-44 3 12 10 6 21 21 
4. 45-64 3 14 11 5 19 27 
5. 65+ 3 7 5 6 13 28 
6.ALL 4 11 10 6 19 22 
Females 1. 15-18 3 10 6 5 15 13 
2. 19-24 4 15 14 8 20 17 
3. 25-44 3 16 9 5 22 22 
4. 45-64 3 14 9 5 18 25 
5. 65+ 2 10 6 5 13 29 
6.ALL 3 13 9 6 19 23 
* Number of glasses/ cups per week of those who consumed the beverage at least once per week. 
Data from the Life in New Zealand Commission Report (Russel & Wilson, 
1991). 
Appendix 3 
Sporting Involvement by New Zealanders over age 15 
Archery, Pistol/Rifle Shooting 3% 




Rink Sports 1% 
Rowing 2% 
Triathlon no data 
Body Building no data 
Power Lifting no data 
NB Participation required an involvement of greater than one month. Male 
respondents=1925, Female respondents=2448. 
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Data from the Life in New Zealand Commission Report (Russel & Wilson, 
1991). 
Appendix 4 
Recommended Schedule of Testing for Banned Substances among the 
Various Sports 
1. Associated Sports NZOCGA 
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SPORT STIMULANTS NARCOTIC ANABOLIC BETA- DIURETICS 
(CAFFEINE) ANALGESICS STEROIDS BLOCKERS 
Archery Comp OOC/Comp OOC/Comp 
Track & Field Comp OOC/Comp OOC/Comp OOC/Comp 
Sprints and Jumps Comp OOC/Comp OOC/Comp Modem pentathlon 
Middle Distance Comp OOC/Comp OOC/Comp 
Long Distance Comp OOC/Comp 
Boxing Comp OOC/Comp OOC/Comp 
Cycling Comp OOC/Comp OOC/Comp 
Fencing Comp OOC/Comp 
Ice Racing Comp OOC/Comp OOC/Comp 
Rowing Comp OOC/Comp OOC/Comp 
Shooting Comp OOC/Comp OOC/Comp 
Weight Lifting Comp OOC/Comp OOC/Comp Comp 
Olympic Wrestling Comp OOC/Comp OOC/Comp Comp 
2. Non-Associated Sports 
SPORT STIMULANTS NARCOTIC ANABOLIC BETA- DIURETICS 
(CAFFEINE) ANALGESICS STEROIDS BLOCKERS 
Triathlon Comp OOC/Comp 
Abbreviations: OOC = Out of competition Testing; Comp = In competition testing 
Adapted from Hatherton et al. (1991). 
Appendix 5 
Letter to National Sport Organisations 
Psychology Department 
University of Canterbury 
Ham 
1 July 1994 
[National Sports Organisation] 
[Address] 
[City] 
To the President 
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I am writing requesting the assistance of your association with some 
work I am undertaking to complete my MSc at the University of 
Canterbury. My thesis involves athletes' perceptions of caffeine, as 
well as the actual use of caffeine amongst new Zealand sports-people 
in different sporting codes. 
My hopes are that National Sports Organisations will assist me in the 
data gathering stage of the process. I am proposing that I send your 
organisation 50 questionnaires for distribution by you to current 
registered athletes in your organisation. These athletes should 
represent all the grading levels from age 18 within the [name of 
association]. All postage costs will be incurred by me, and your 
commitment, should you wish to take part in this, will be only to 
address the packages. However, if you could make a mailing list 
available to me, I can take over this responsibility also. 
Each athlete will receive a consent form to be signed, and various 
questionnaires assessing their level of involvement in their sport, 
their consumption of caffeine, and their perceptions of caffeine. They 
will also have in their package a demographic questionnaire and a 
self-addressed pre-paid envelope in order to send the completed 
questionnaires back to me. 
Assurance of complete confidentiality is given to every athlete 
partaking in this study, and they will also be given a summary of 
findings once the results have been collated. Your organisation will 
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also receive summary findings and sample questionnaires for your 
records. 
Should you wish to be involved in this study, please drop me a line at 
the above address or fax number at your earliest possible 
convenience. I would be very grateful to have the assistance of the 
[name of organisation], and trust that the results could be valuable to 
you. 
Yours sincerely 
Anita van Maanen 
(Researcher) 
Appendix 6 
National Sports Organisations to whom Requests were Sent 
Athletics New Zealand replied, offered assistance 
New Zealand Boxing Association Inc. no reply 
Cycling New Zealand replied, offered assistance 
Ice Racing Federation of New Zealand Inc. replied, offered assistance 
New Zealand Power Lifting Federation no reply 
New Zealand Rowing Association replied, declined assistance 
New Zealand Shooting Federation Inc. no reply 
Triathlon New Zealand replied, offered assistance 
New Zealand Olympic Wrestling Union Inc. no reply 
New Zealand Body Building no reply 
New Zealand Amateur Fencing Association no reply 
New Zealand Archery Association no reply 
Appendix 7 
Final List of Organisations which Distributed Questionnaires 
Athletics New Zealand 
Canterbury Boxing Association 
Cycling New Zealand 
Ice Racing Federation of New Zealand Inc. 
Canterbury Powerlifting Federation 
Union Rowing Club (to rowers affiliated to NZARA in Canterbury) 
Canterbury Small Bore Rifle Association 
Triathlon New Zealand 
New Zealand Olympic Wrestling Union Inc. 
Representative of New Zealand Federation of Body Builders 
Canterbury Fencing Association 




Letter of Introduction to Athletes 
Dear Athlete 
I am writing requesting your assistance with some research into the 
use of caffeine as an ergogenic (performance-enhancing) agent and 
the consequences of caffeine use as athletes perceive them. Your 
name was randomly selected by the organisation to which you are 
affiliated, along with 549 other athletes in various sporting codes. 
The study, I hope, will be of interest, not only to you, but also to 
coaches, administrators, and athletes of other disciplines. Enclosed 
you will find questionnaires which are to be completed, and a 
consent form to be signed. 
Please accept my assurance of complete confidentiality. The finished 
thesis will not include your name, and all records can be destroyed at 
your request. However, the aggregated results will be included in the 
final thesis. 
The success of this research is dependent entirely upon your 
assistance in completing these questionnaires honestly. This involves 
some degree of commitment on your part but your organisation will 
subsequently receive beneficial information from your participation. 
Please fill in these questionnaires and return them to me, along with 
the signed consent form as soon as possible. There is no postage 
required. If you have any questions, please do not hesitate to call me 
during office hours on (03) 364-2391 or after hours on (03) 327-
7711. Thankyou for your assistance, and good training. 
Kind regards, 
Anita van Maanen (Researcher) 




DEPARTMENT OF PSYCHOLOGY 
CONSENT FORM 
Reason for the project: To generate data about the use of caffeine by 
New Zealand athletes in various sports and to assess the beliefs these 
athletes have about the pharmacological, physiological, and 
psychological effects of caffeine administration. 
Your tasks in this project: To complete and return the questionnaires 
issued to you. 
Risks associated with participation: There are no risks associated 
with participation. 
Confidentiality: All medical information and test results will be held 
in strictest confidence, and records destroyed at your request. Your 
organisation will be given a copy of results obtained from the study. 
This will include aggregated results from all subjects, and not the 
results from your individual participation. 
Voluntary participation: Your permission to partake in this study is 
voluntary. You are free to deny consent or refrain from participation if 
you so desire. However, your assistance would be greatly appreciated. 
Time required: The questionnaire pack should take between 15 and 
30 minutes too complete. 
Researcher: Anita L. van Maanen Supervisor: Dr. Rob Hughes 
I agree to participate in the project described above, on 
the understanding that if at any time I wish to withdraw 
from the experiment I may, without prejudice, do so. All 
information collected will be confidential as will the 
identity of participants. 




'IJ'E/MO(j1(MJ-£IC Q'll'ESCJ'I09{,:A{f4_I1('E DEMO-Q 
'Tlie purpose of tfiis questionnaire is to o6tain a genera{ picture of your 6acKground. 
In scientific worf<t records are necessary1 since tfiey pennit an accurate description 
of tfie study popu{ation. P{ease answer tfiese routine questions in your own time. 
P{ease p{ace tfie num6er of your cfioice in tfie 60,r, at tlie rigfit of tfie page. 
It is understanda6{e tfiat you migfit 6e concerned a6out wfiat fiappens to tfie 
information a6out you, 6ecause mucfi of tliis information is liigfi[g persona{. yl{{ 
records are strict{g confo{entiaf. !A(p outsider is pennitted to see tliis information 
witfiout your pennission. 
Your gender ed. 5 
1. Male • 2. Female 
Your age 
1. 18 - 25 • 2. 26 - 30 
3. 31 - 35 
4. 36 - 40 
5. 41 - 45 
6. 46 - 50 
Gross personal income for 1994 
1. less than $10 000 • 2. $10 001 - $20 000 
3. $20 001 - $30 000 
4. $30 001 - $40 000 
5. $40 001 - $50 000 
6. more than $50 000 
Total household income for 1994 
1. less than $10 000 • 2. $10 001 - $20 000 col. 8 
3. $20 001 - $30 000 
4. $30 001 - $40 000 
5. $40 001 - $50 000 
6. more than $50 000 
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Appendix 10 cont. 
Re1ationship status 
1. single • 2. married 




Number of children (born to you or under your care) 




5. over four 
Ethnic origin 




* 'fy spec1 .............................................. . 
Highest qualification achieved 
1. School Certificate • 2. Sixth Form Certificate col. 12 
3. University Entrance 
4. Bursary 'B' 
5. Bursary 'A' 
6. Scholarship 
7. University degree/ diploma 
*specify .......................................................... . 
8. Other 
*specify ............................................................ . 
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Appendix 11 
Caffeinism Symptoms Questionnaire 
CAFF-SX 
To what extent do you purposely choose non-caffeinated beverages? 
1. Always • 2. Usually col. 14 
3. Sometimes 
4. Never 
Was the last drink/soft drink you consumed: 
1. Caffeinated • 2. Caffeine-free 
3. Don't know 
(If you responded ' Don't know', what was your last drink? _____ _ 
Does caffeine enhance performance in your sport? 
1. Yes • 2. No 
3. Sometimes 
4. Don't know 







Insomnia (inability to sleep) 
• • • 
col. 19 
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Appendix 11 cont. 






Diuresis (frequent need to urinate) 
Gastrointestinal disturbance 
Muscle twitching 
Impaired thought and/ or speech 
Pounding heart or palpitations 
Periods of inexhaustibility 
col. 20 
• • • • • • • 
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Appendix 12 
P'E'i\CEI'f}E/JJ CO'J.[S'EQ'll'E'}[{:ES O:F CYL:F:F'EI~ EP-CAFF. l 
'Tfiis questionnaire is designed to assess your 6e{iefs a6out tfie cfiaracteristics of 
caffeine and caffeinated 6everages. Pfease indicate your answer 6y pfacing tfie 





Caffeinated beverages taste good ................................................. . 
Caffeine causes cancer .................................................................... . 
Caffeine helps drunk people sober up .................................... .. 
Caffeine helps me feel better ...................................................... .. 
Caffeine helps me relax ................................................................ .. 
Caffeine makes people irritable .................................................. .. 
Caffeine gives people high blood pressure ............................... . 
Caffeine makes people urinate often ....................................... .. 
Caffeine is bad for teeth .............................................................. .. 
Caffeine damages the kidneys and bladder ............................ .. 















Appendix 12 cont. 
1. Yes 2. No 3. Umure col.40 
Caffeine makes people gain weight. ......................................... . • 
Caffeine helps people think more clearly ............................ . • 
Caffeine makes people feel shaky and jittery ....................... . • 
Caffeinated beverages are refreshing ......................................... . • 
Caffeine upsets the stomach ......................................................... . • 
Caffeine causes acne ........................................................................ . • 
Caffeine makes people nervous and anxious ......................... . • 
Caffeine keeps people awake when they're tired .................. . • 
Caffeine causes headaches .............................................................. . • 
Caffeine causes ulcers ...................................................................... . • 
Caffeine is harmful to health ..................................................... .. • 
Caffeine helps people perform better ....................................... .. • 
Caffeinated beverages are habit-forming .................................. .. • 
Caffeine gives people more energy .......................................... .. • 




¥E'RCEI'VE/1J C09\[S'EQ'll'E/).{C£S O:f C.91:f :f'EI9fl:, E P-CAFF. 2 
'This questionnaire is designed to assess your Gdiefs a6out the cfiaracteristic.s of 
caffeine as they refate to sport. PCease indicate your answer Gy pfacing the numGer 
of the answer which Gest ref{ects your 6dief in the 6ox_ at the right of the page. 
1. Yes 2. No 3. Unsme col. 56 
In my sport, caffeine enables one to work for longer before fatigue ......... . 
In my sport, caffeine increases fat utilisation ................................................ .. 
In my sport, caffeine helps spare muscle glycogen stores ............................ . 
In my sport, the supposed effects of caffeine are psychological.. ............... .. 
The more caffeine consumed, the more performance improves ............. .. 
Caffeine reduces tremors (for example, shaky hands) ................................. .. 
Caffeine can be of benefit in endurance sports .............................................. .. 
Caffeine can be of benefit in sports requiring alertness ............................... .. 
Caffeine can be of benefit in sports requiring low anxiety levels .............. .. 
Caffeine can be of benefit in sports requiring strength and power. .......... .. 
Caffeine can help athletes lose body fat .......................................................... .. 
Very high doses of caffeine can impair sports performance ...................... .. 

















SPO!R:l SPECIJIC Q'llfilrr'I00[,0{fl.I'R_,'E SPORT-Q 
rr'liis questwnnaire is designed to get some informatwn rerevant to your invo{vement 
in sport. P(ease answer the questwns lionest{g and to the 6est of your R..,now{edge. 
Indicate your answers 6y pCacing tlie num6er of choice in the rig/it hand 6oKi 
What is the main reason you participate in sport? 
1. Improve skills 
2. Enjoy the competition 
3. Maintain fitness 
4. Wish to represent New Zealand 
5. Recognition 
6. Social contact 
How many years have you been involved competitively in this sport? 
1. Less than three years 2. Between three and six years 
3. More than six years 
What is your highest level of participation? 
1. Local community based competition 
2. Regional competition 
3. National competition 
4. International competition 
How many hours do train per week during in-season? 
1. 0- 7 2. 7-14 3. 14-21 4. Morethan21 
Do you consume caffeine for its performance enhancing effects? 
1. Yes 2. No 3. Sometimes 
If you answered 1 or 31 how long have you been using caffeine as a 
performance enhancing drug? 
1. Less than 1 year 2. 1 - 2 years 3. 2 - 3 years 
4. 3 - 4 years 5. 4 - 5 years 6. More than 5 years 
Have you ever intentionally used caffeine in competition to enhance 
performance knowing that you risk disqualification if urine levels of 
caffeine are high enough? 











Athletic Identity Measurement Scale 
AIMS 
Pfease rate tfie way you fee{ in terms of tfie statements given 6e{ow. 
1. Strongly agree 
2. Agree 
3. Neither agree nor disagree 
4. Disagree 
5. Strongly disagree 
I consider myself an athlete. 
I have many goals related to sport. 
Most of my friends are athletes. 
Sport is the most important part of my life. 
I spend more time thinking about sport than 
anything else. 
I need to participate in sport to feel good about myself. 
Other people see me mainly as an athlete. 
I feel bad about myself when I do poorly in sport. 
Sport is the only important thing in my life. 
I would be very depressed if I were injured and could 














C5'l:f!PEIN.';£, I'Jl{,'T5l'l('E Q'U'ES'TIO'.Af.,'J{:4.I'l('E T-CAFF 
%is questionnaire is aesignea to get some information about tfie amount of caffeine you 
consume. Puase estimate your aauy caffeine consumption Gy pfacing tfie quantity insufe eacli 
GracRf-t as app[icaGu. 
ITEM QUANTITY 
Coffee: 

















( ) cups 
( ) cups 
( ) cups 
( ) cups 
( ) cups 
( ) cups 
( ) cups 
( ) cups 
( ) heaped teaspoons 
( ) heaped teaspoons 
( ) grams (approx.) 
( ) grams (approx.) 
( ) cans (333ml) 
( ) cans (333ml) 
( ) bottles (500 ml) 
Prescription and Over-the-Counter Medications: 
Cafergot ( ) tablets 
Fiorinal ( ) tablets 
Soma Compound ( ) tablets 
Darvon Compound ( ) tablets 
Weight-Control Aids: 
please specify_________ ( ) 
Alertness Tablets: 
please specify_________ ( ) 
Analgesic/Pain relief: 
please specify_________ ( ) 
Diuretics: 
please specify ________ _ 
Cold/ Allergy Remedies: 








Competition Entry Form 
PLEASE ACCEPT THIS FREE J MONTH MEMBERSHIP 
FOR YOU OR A FRIEND 
AND GO IN THE DRAW FOR A FREE 
AT LES MILLS WORLD OF FITNESS 
IN CHRISTCHURCH 
VALUED AT $395 
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JUST FILL IN THE DETAILS BELOW AND RETURN THIS SLIP, TOGETHER WITH YOUR 
COMPLETED QUESTIONNAIRE IN THE ENVELOPE PROVIDED. 
NOTE: 1. Entries in the competition and signed consent forms are immediately separated from the 
questionnaire to keep your identity confidential. Furthermore, the green 3--digit identifier number on your 
questionnaire is not printed on either the consent form or the competition entry form in order to preserve 
your anonymity. 
2. If you are not a Christchurch resident, you can transfer the membership into the name of a friend/ relative 
who resides in Christchurch. Unfortunately the membership cannot be exchanged for cash or uplifted at 
another Les Mills World of Fitness branch. 
3. I would like to thank Les Mills (Ch Ch) for the donation of memberships . 





Distribution of Subjects According to AIMS Ratings 
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Appendix:20 
Distribution of Subjects According to Caffeine Beliefs 
: JI:lllf::!lll!!l~ttl::fifbfl!:ffI 
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Distribution of Subjects According to Beliefs of Caffeine 




Distribution of Athletes by Endorsement of Caffeinism Symptoms 
